Biyografi
|
||
Eğitim Bilgileri
1988 - 1990
1988 - 1990Tıpta Yandal Uzmanlık
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1978 - 1983
1978 - 1983Tıpta Uzmanlık
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1972 - 1978
1972 - 1978Lisans
Ankara Üniversitesi, Tıp Fakültesi, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Sağlık Bilimleri
Akut Lösemi,Kronik Lösemi,Hodgkin Lenfoma,Hodgkin Dışı Lenfoma,Multipl Miyeloma,MDS,Aplastik Anemi,Kök Hücre, Kemik İliği Nakli,Hemaferez,Geriatrik Hematoloji,Tele Hematoloji,Kanser Kök Hücresi,Anemi,Kanama Diyatesi,Tromboz,Pıhtılaşma Bozuklukları,
Akademik Unvanlar / Görevler
2024 - Devam Ediyor
2024 - Devam EdiyorProf. Dr.
Lokman Hekim Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1978 - 2023
1978 - 2023Prof. Dr.
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2024 - Devam Ediyor
2024 - Devam EdiyorAnabilim Dalı Akademik Kurul Üyesi
Lokman Hekim Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2021 - 2022
2021 - 2022Bölüm Başkanı
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2019 - 2022
2019 - 2022Anabilim/Bilim Dalı Başkanı
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2003 - 2006
2003 - 2006Anabilim/Bilim Dalı Başkanı
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1993 - 1996
1993 - 1996Anabilim/Bilim Dalı Başkanı
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
2024
2024Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Lahmer T., Salmanton-García J., Marchesi F., El-Ashwah S., Nucci M., Besson C., et al.
Infection
, cilt.52, sa.3, ss.1125-1141, 2024 (SCI-Expanded)
2024
2024The effect of danger-associated molecular patterns on survival in acute graft versus host disease
Çelik S., KAYNAR L., Güven Z. T., Atasever Duran K., KONTAŞ O., KEKLİK M., et al.
Bone Marrow Transplantation
, cilt.59, sa.2, ss.189-195, 2024 (SCI-Expanded)
2024
2024Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry
Musto P., Salmanton-García J., Sgherza N., Bergantim R., Farina F., Glenthøj A., et al.
Hematological Oncology
, cilt.42, sa.1, 2024 (SCI-Expanded)
2023
2023The world apheresis association registry, 2023 update
Vrielink H., Le Poole K., Stegmayr B., Kielstein J., Berlin G., İLHAN ., et al.
Transfusion and Apheresis Science
, cilt.62, sa.6, 2023 (SCI-Expanded)
2023
2023Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
Rossi G., Salmanton-García J., Cattaneo C., Marchesi F., Dávila-Valls J., Martín-Pérez S., et al.
International Journal of Infectious Diseases
, cilt.137, ss.98-110, 2023 (SCI-Expanded)
2023
2023Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation
Merter M., Sahin U., İLHAN ., Beksac M.
Journal of Clinical Apheresis
, cilt.38, sa.6, ss.685-693, 2023 (SCI-Expanded)
2023
2023Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study
Arat M., Alacacioglu I., Bolaman A. Z., Buyukasik Y., Cagirgan S., Güvenc B., et al.
Future Oncology
, cilt.19, sa.14, ss.975-982, 2023 (SCI-Expanded)
2023
2023Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome
Beksac M., CENGİZ SEVAL G., Koyun D., TOPÇUOĞLU P., YÜKSEL M., Gurman G., et al.
Clinical Lymphoma, Myeloma and Leukemia
, cilt.23, sa.3, 2023 (SCI-Expanded)
2023
2023Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
Kırcalı E., Seval G. C., Öztürk C., Yılmaz H., Koyun D., Bozdağ S. C., et al.
Balkan Medical Journal
, cilt.40, sa.1, ss.51-56, 2023 (SCI-Expanded)
2023
2023Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
CENGİZ SEVAL G., Bozdag S. C., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Balkan Medical Journal
, cilt.40, sa.3, ss.197-204, 2023 (SCI-Expanded)
2023
2023Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Busca A., Salmanton-García J., Marchesi F., Farina F., Seval G. C., Van Doesum J., et al.
Frontiers in Immunology
, cilt.14, 2023 (SCI-Expanded)
2022
2022Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients
Gokmen A., Sahin U., Soydan E., Gokgoz Z., Okcu M. K., Ozan U., et al.
Clinical Lymphoma, Myeloma and Leukemia
, cilt.22, sa.10, 2022 (SCI-Expanded)
2022
2022Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation
DALVA K., HASKOLOĞLU Z. Ş., DALVA AYDEMİR S., Oz M. D., ÖZTÜRK BİRGE A., Ipek S., et al.
Experimental and Clinical Transplantation
, cilt.20, sa.10, ss.937-944, 2022 (SCI-Expanded)
2022
2022Prognostic factors in thrombotic thrombocytopenic purpura
Yalçıner M., İlhan O.
Turkish Journal of Biochemistry
, cilt.47, sa.5, ss.626-632, 2022 (SCI-Expanded)
2022
2022Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia
Ozdemir Z. N., Kircali E., Şahin U., Seval G. C., Bozdağ S. C., Toprak S. K., et al.
Clinical Lymphoma, Myeloma and Leukemia
, cilt.22, sa.8, ss.596-600, 2022 (SCI-Expanded)
2022
2022COVID-19 and hairy-cell leukemia: An EPICOVIDEHA survey
Lamure S., Salmanton-García J., Robin-Marieton E., Jaksic O., Kohn M., Marchesi F., et al.
Blood Advances
, cilt.6, sa.13, ss.3870-3874, 2022 (SCI-Expanded)
2022
2022Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease
Koyun D., CENGİZ SEVAL G., Kırcalı E., Bozdağ S. C., TOPRAK S. K., TOPÇUOĞLU P., et al.
Indian Journal of Hematology and Blood Transfusion
, cilt.38, sa.3, ss.601-605, 2022 (SCI-Expanded)
2022
2022Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Soran H., Freiberger T., Harada-Shiba M., Cuchel M., Tromp T. R., Tromp T. R., et al.
The Lancet
, cilt.399, sa.10326, ss.719-728, 2022 (SCI-Expanded)
2022
2022Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial
Garcia-Manero G., Mufti G. J., Fenaux P., Buckstein R., Santini V., Díez-Campelo M., et al.
Blood
, cilt.139, sa.4, ss.624-629, 2022 (SCI-Expanded)
2022
2022Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies COVID-19 Geçiren Türk Hematolojik Malignite Hastalarının Klinik Özellikleri ve Sonuçları
Bozdağ S. C., Seval G. C., Hindilerden İ. Y., Hindilerden F., Andıç N., Baydar M., et al.
Turkish Journal of Hematology
, cilt.39, sa.1, ss.43-54, 2022 (SCI-Expanded)
2021
2021COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Pagano L., Salmanton-García J., Marchesi F., Busca A., Corradini P., Hoenigl M., et al.
Journal of Hematology and Oncology
, cilt.14, sa.1, 2021 (SCI-Expanded)
2021
2021Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor-discontinuation” in chronic myeloid leukemia
İLHAN ., Narli Ozdemir Z., DALVA K., Arslan A., Okay Ozgeyik M., Ipek S., et al.
International Journal of Laboratory Hematology
, cilt.43, sa.5, ss.1110-1116, 2021 (SCI-Expanded)
2021
2021Analysis of extracorporeal photopheresis within the frame of the WAA register
Blaha M., Gasova Z., Berlin G., Audzijoniene J., Griskevicius A., Dykes J., et al.
Transfusion and Apheresis Science
, cilt.60, sa.5, 2021 (SCI-Expanded)
2021
2021Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis
Stegmayr B., Newman E., Witt V., Derfler K., Leitner G., Eloot S., et al.
Transfusion Medicine and Hemotherapy
, cilt.48, sa.4, ss.234-239, 2021 (SCI-Expanded)
2021
2021Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study
Stilgenbauer S., Bosch F., İLHAN ., Kisro J., Mahé B., Mikuskova E., et al.
British Journal of Haematology
, cilt.193, sa.2, ss.325-338, 2021 (SCI-Expanded)
2021
2021Kronik Lenfositik Lösemide Lösemik İnfiltrasyona Bağlı Akut Böbrek Yetmezliği
Şahin G. K., Kocabay H. E., Kiremitçi S., İlhan O., Keven K.
Turkish Journal of Hematology
, cilt.38, sa.2, ss.167-168, 2021 (SCI-Expanded)
2021
2021Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy
Narli Ozdemir Z., Cengiz Seval G., Sahin U., Uslu A., Gunduz M., Civriz Bozdag S., et al.
Indian Journal of Hematology and Blood Transfusion
, cilt.37, sa.1, ss.67-75, 2021 (SCI-Expanded)
2021
2021Highlighting the prognostic importance of measurable residual disease among acute myeloid leukemia risk factors Akut myeloid lösemi risk faktörleri arasında ölçülebilir kalıntı hastalığın prognostik öneminin vurgulanması
Özdemir Z. N., Şahin U., Dalva K., Baltacı M. A., Uslu A., Öztürk C., et al.
Turkish Journal of Hematology
, cilt.38, sa.2, ss.111-118, 2021 (SCI-Expanded)
2021
2021Acute kidney injury due to leukemic infiltration in a patient with chronic lymphocytic leukemia Kronik lenfositik lösemide lösemik infiltrasyona bağlı akut böbrek yetmezliği
KUMRU G., Kocabay H. E., KİREMİTCİ S., İLHAN ., KEVEN K.
Turkish Journal of Hematology
, cilt.38, sa.2, ss.167-168, 2021 (SCI-Expanded)
2020
2020Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation
Ataca Atilla P., Akkus E., Atilla E., Gokmen N., Civriz Bozdag S., Kurt Yuksel M., et al.
Clinical Transplantation
, cilt.34, sa.10, 2020 (SCI-Expanded)
2020
2020Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation Effets de l'incompatibilité ABO pour l'allogreffe de cellules souches hématopoïétiques
Ataca Atilla P., Akkus E., Atilla E., Gökmen İnan N., Civriz Bozdag S., Kocak Toprak S., et al.
Transfusion Clinique et Biologique
, cilt.27, sa.3, ss.115-121, 2020 (SCI-Expanded)
2020
2020Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma
Beksac M., Aydin Y., Goker H., Turgut M., Besisik S. K., Cagirgan S., et al.
Clinical Lymphoma, Myeloma and Leukemia
, cilt.20, sa.8, 2020 (SCI-Expanded)
2020
2020Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)
Kuman Tunçel Ö., Kayıkçıoğlu M., Pırıldar Ş., Yılmaz M., Kaynar L., Aktan M., et al.
Journal of Clinical Lipidology
, cilt.14, sa.3, ss.361, 2020 (SCI-Expanded)
2020
2020Luspatercept in patients with lower-risk myelodysplastic syndromes
Fenaux P., Platzbecker U., Mufti G. J., Garcia-Manero G., Buckstein R., Santini V., et al.
New England Journal of Medicine
, cilt.382, sa.2, ss.140-151, 2020 (SCI-Expanded)
2020
2020Study for the diagnostic screening of paroxysmal nocturnal hemoglobinuria in older patients with unexplained anemia and/or cytopenia
Ozdemir Z. N., İLHAN ., Ozet G., Falay M., YENEREL M. N., Tuglular T., et al.
Clinical Laboratory
, cilt.66, sa.9, ss.1709-1715, 2020 (SCI-Expanded)
2020
2020Who 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitors Kronik myeloid lösemi who 2016 tanımlaması ve tirozin kinaz inhibitörleri
HAZNEDAROĞLU İ. C., KUZU I., İLHAN .
Turkish Journal of Hematology
, cilt.37, sa.1, ss.42-47, 2020 (SCI-Expanded)
2019
2019Who 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
Haznedaroğlu İ. C., Kuzu I., İLHAN O.
TURKISH JOURNAL OF HAEMATOLOGY , 2019 (SCI-Expanded)
2019
2019Evaluation of health and quality of life in apheresis patients – data from the WAA register
Goto J., Newman E., Witt V., Deeren D., Blaha M., Lanska M., et al.
Transfusion and Apheresis Science
, cilt.58, sa.5, ss.641-644, 2019 (SCI-Expanded)
2019
2019Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients
İLHAN ., Ozdemir Z. N., Ozet G., Falay M., Yenerel M., Tuglular T., et al.
Transfusion and Apheresis Science
, cilt.58, sa.5, ss.659-662, 2019 (SCI-Expanded)
2019
2019A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System
Kilic P., Bay M., Yildirim Y., Coskun O., Seker S., Baydin P., et al.
Cells Tissues Organs
, cilt.207, sa.1, ss.15-20, 2019 (SCI-Expanded)
2019
2019Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
Dagnew A. F., İLHAN ., Lee W., Woszczyk D., Kwak J., Bowcock S., et al.
The Lancet Infectious Diseases
, cilt.19, sa.9, ss.988-1000, 2019 (SCI-Expanded)
2019
2019Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
Kayikcioglu M., Kuman-Tunçel O., Pirildar S., Yílmaz M., Kaynar L., Aktan M., et al.
Journal of Clinical Lipidology
, cilt.13, sa.3, ss.455-467, 2019 (SCI-Expanded)
2019
2019Comparison of the methods evaluating post thawing viability of peripheral blood stem cell graft
Varan H. D., BAY M., ÖZTÜRK BİRGE A., DALVA K., İLHAN .
Transfusion and Apheresis Science
, cilt.58, sa.2, ss.192-195, 2019 (SCI-Expanded)
2019
2019Early initiation of extracorporeal photochemotherapy increases response for chronic graft versus host disease following steroid failure L'initiation précoce de la photochimiothérapie extracorporelle augmente la réponse pour la maladie chronique du greffon contre l'hôte après échec des stéroïdes
Gunduz M., Atilla E., Atilla P., TOPÇUOĞLU P., İLHAN .
Transfusion Clinique et Biologique
, cilt.26, sa.1, ss.32-37, 2019 (SCI-Expanded)
2019
2019Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016
Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Koçak A. A., Karatayli S. C., et al.
Turkish Journal of Gastroenterology
, cilt.30, sa.11, ss.957-963, 2019 (SCI-Expanded)
2018
2018Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice
Durdu M. S., Cakici M., Gumus F., Deniz G. C., Bozdag S. C., ÖZÇINAR E., et al.
Transfusion and Apheresis Science
, cilt.57, sa.6, ss.762-767, 2018 (SCI-Expanded)
2018
2018Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up
Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.
Hematology
, cilt.23, sa.10, ss.771-777, 2018 (SCI-Expanded)
2018
2018What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M., Tokgozoglu L., Dogan V., Ceyhan C., Tuncez A., Kutlu M., et al.
Atherosclerosis
, cilt.277, ss.341-346, 2018 (SCI-Expanded)
2018
2018Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA external quality assessment national program results MOTAKK HBV DNA ve HCV RNA diş kalite kontrol ulusal programi 2015-2016 sonuçlarinin deǧerlendirilmesi
Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Altay Koçak A., Karatayli S. C., et al.
Mikrobiyoloji Bulteni
, cilt.52, sa.4, ss.348-366, 2018 (SCI-Expanded)
2018
2018Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
Stilgenbauer S., Leblond V., Foà R., Böttcher S., İLHAN ., Knauf W., et al.
Leukemia
, cilt.32, sa.8, ss.1778-1786, 2018 (SCI-Expanded)
2018
2018Biography
İLHAN .
Transfusion and Apheresis Science
, cilt.57, sa.2, ss.151, 2018 (SCI-Expanded)
2018
2018Editorial
İLHAN .
Transfusion and Apheresis Science
, cilt.57, sa.2, ss.150, 2018 (SCI-Expanded)
2018
2018JACIE: A 20 year-old voluntary body functioning worldwide
YÜKSEL M., İLHAN .
Transfusion and Apheresis Science
, cilt.57, sa.2, ss.153-158, 2018 (SCI-Expanded)
2018
2018Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: Primary analysis of the randomized, open-label mable study
Michallet A., Aktan M., Hiddemann W., İLHAN ., Johansson P., Laribi K., et al.
Haematologica
, cilt.103, sa.4, ss.698-706, 2018 (SCI-Expanded)
2018
2018A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
Kayikcioglu M., Tokgozoglu L., Yilmaz M., Kaynar L., Aktan M., Durmuş R. B., et al.
Atherosclerosis
, cilt.270, ss.42-48, 2018 (SCI-Expanded)
2018
2018Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: A retrospective study
Atilla E., Sahin D., Atilla P. A., DOLAPÇI G. İ., TEKELİ F. A., Bozdag S. C., et al.
Antiviral Therapy
, cilt.23, sa.6, ss.523-527, 2018 (SCI-Expanded)
2018
2018Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?
Atilla E., Yalciner M., Atilla P. A., Ates C., Bozdag S. C., Yuksel M. K., et al.
Antiviral Therapy
, cilt.23, sa.8, ss.647-653, 2018 (SCI-Expanded)
2017
2017DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia
Ozdogan H., GÜR DEDEOĞLU B., Oztemur Islakoglu Y., Aydos A., KÖSE S., ATALAY A., et al.
Leukemia Research
, cilt.63, ss.62-71, 2017 (SCI-Expanded)
2017
2017Extracorporeal photochemotherapy in mycosis fungoides Photochimiothérapie extracorporelle dans les mycoses fongiques
Atilla E., Atilla P., Bozdag S., Yuksel M., Toprak S., Topcuoglu P., et al.
Transfusion Clinique et Biologique
, cilt.24, sa.4, ss.454-457, 2017 (SCI-Expanded)
2017
2017Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: The randomized MabEase study
Lugtenburg P., Avivi I., Berenschot H., İLHAN ., Marolleau J. P., Nagler A., et al.
Haematologica
, cilt.102, sa.11, ss.1913-1922, 2017 (SCI-Expanded)
2017
2017Subsequent malignancies after allogeneic hematopoietic stem cell transplantation
Gündüz M., Özen M., Şahin U., Toprak S. K., Civriz Bozdağ S., Kurt Yüksel M., et al.
Clinical Transplantation
, cilt.31, sa.7, 2017 (SCI-Expanded)
2017
2017Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study
ÖZEN M., ÜSTÜN C., ÖZTÜRK B., TOPÇUOĞLU P., ARAT M., GÜNDÜZ M., et al.
Turkish Journal of Hematology
, cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded)
2017
2017Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms
SOYER N., HAZNEDAROĞLU İ. C., CÖMERT M., ÇEKDEMİR D., YILMAZ M., ÜNAL A., et al.
Turkish Journal of Hematology
, cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded)
2017
2017The effect of age on peripheral stem cell mobilization in healthy donors, single center experience
Ozen M., Gunduz M., TOPÇUOĞLU P., TOPRAK S. K., DALVA K., Gurman G., et al.
Journal of Clinical Apheresis
, cilt.32, sa.1, ss.16-20, 2017 (SCI-Expanded)
2017
2017Multicenter retrospective analysis of turkish patients with chronic myeloproliferative neoplasms Kronik miyeloproliferatif neoplazi tanılı türk hastaların geriye dönük ve çok merkezli analizi
Soyer N., HAZNEDAROĞLU İ. C., Cömert M., Çekdemir D., Yılmaz M., ÜNAL A., et al.
Turkish Journal of Hematology
, cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded)
2017
2017Allogeneic transplantation in chronic myeloid leukemia and the effect of tyrosine kinase inhibitors on survival: A quasi-experimental study Kronik myeloit lösemide allojenik nakil ve tirozin kinaz inhibitörlerinin sağkalıma etkisi bir öncesi-sonrası çalışması
Özen M., Üstün C., Öztürk B., Topçuoğlu P., Arat M., Gündüz M., et al.
Turkish Journal of Hematology
, cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded)
2017
2017Constitutional Trisomy 8 Mosaicism with Persistent Macrocytosis
Altlner Ş., KUTLAY N., İLHAN .
Cytogenetic and Genome Research
, cilt.150, sa.1, ss.35-39, 2017 (SCI-Expanded)
2016
2016Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders
AKSU S., AYYILDIZ O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
Uluslararası Hematoloji-Onkoloji Dergisi
, cilt.26, sa.Suppl 1, ss.12-19, 2016 (SCI-Expanded)
2016
2016Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study
O'Brien S., Jones J. A., Coutre S. E., Mato A. R., Hillmen P., Tam C., et al.
The Lancet Oncology
, cilt.17, sa.10, ss.1409-1418, 2016 (SCI-Expanded)
2016
2016Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase
Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.
Expert Opinion on Pharmacotherapy
, cilt.17, sa.14, ss.1851-1858, 2016 (SCI-Expanded)
2016
2016A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction
ÖZEN M., YILMAZ G., COŞKUN B., TOPÇUOĞLU P., ÖZTÜRK B., GÜNDÜZ M., et al.
Turkish Journal of Hematology
, cilt.33, sa.1, ss.41-47, 2016 (SCI-Expanded)
2016
2016Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates
Tekgündüz E., Şencan I., Kapuağasi A., Ünal D., Öztürk M., Gümüş E., et al.
Transfusion and Apheresis Science
, cilt.54, sa.1, ss.53-59, 2016 (SCI-Expanded)
2016
2016Idelalisib at the crossroads of B-cell lymphoproliferative disorders B-Hücreli lenfoproliferatif hastalıkların dönüm noktası İdelalisib
AKSU S., Ayyildiz O., Etgul S., GÖKER H., Gunes G., HAZNEDAROĞLU İ. C., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.26, ss.12-19, 2016 (SCI-Expanded)
2016
2016A quasi-experimental study analyzing the effectiveness of portable high-efficiency particulate absorption filters in preventing infections in hematology patients during construction İnşaat esnasında hematoloji hastalarında gelişen enfeksiyonların önlenmesinde portabl yüksek etkinlikte partikül emici filtrelerin etkinliğinin değerlendirildiği bir öncesi sonrası Çalışması
Özen M., Yılmaz G., Coşkun B., Topçuoğlu P., Öztürk B., Gündüz M., et al.
Turkish Journal of Hematology
, cilt.33, sa.1, ss.41-47, 2016 (SCI-Expanded)
2015
2015Antilymphocyte/Thymocyte Globulin for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: 20-Year Experience at a Single Center
ÖZEN M., BOZDAG S. C., CAKMAK G., TOPÇUOĞLU P., EROGLU A. H., GÜNDÜZ M., et al.
Uluslararası Hematoloji-Onkoloji Dergisi
, cilt.25, sa.4, ss.236-244, 2015 (SCI-Expanded)
2015
2015Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting
CAN A., Ulus A. T., ÇINAR Ö., TOPAL ÇELİKKAN F., Simsek E., AKYOL M., et al.
Stem Cell Reviews and Reports
, cilt.11, sa.5, ss.752-760, 2015 (SCI-Expanded)
2015
2015Peripheral blood stem cell mobilization and collection from elderly patients and elderly healthy donor
Bozdag S. C., İLHAN .
Transfusion and Apheresis Science
, cilt.53, sa.1, ss.8-12, 2015 (SCI-Expanded)
2015
2015Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: Results of the randomized NHL13 trial
Jaeger U., Trneny M., Melzer H., Praxmarer M., Nawarawong W., Yehuda D. B., et al.
Haematologica
, cilt.100, sa.7, ss.955-963, 2015 (SCI-Expanded)
2015
2015Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study
Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., et al.
Geriatrics and Gerontology International
, cilt.15, sa.6, ss.729-735, 2015 (SCI-Expanded)
2015
2015Hyperviscosity in renal transplant recipients
Tutal E., Erkmen Uyar M., Uyanik S., Bal Z., Guliyev O., TOPRAK S. K., et al.
Transplantation Proceedings
, cilt.47, sa.4, ss.1165-1169, 2015 (SCI-Expanded)
2015
2015Clinical characteristics, post-treatment assessment and prognostic factors affecting patient survival of patients at 65 years of age or older with hodgkin lymphoma: A retrospective multicenter study from Turkey
Berber I., Erkurt M. A., Keklik M., Dogu M. H., Terzi H., Pala C., et al.
Acta Medica Mediterranea
, cilt.31, sa.6, ss.1195-1202, 2015 (SCI-Expanded)
2015
2015Antilymphocyte/thymocyte globulin for the treatment of steroid-refractory acute graft-versus-host disease: 20-year experience at a single center Steroide dirençli akut graft versus host hastalığının tedavisinde antilenfosit / Timosit globulin: Bir merkezdeki 20 yıllık deneyim
Ozen M., Bozdag S. C., Cakmak G., TOPÇUOĞLU P., EROĞLU A. H., Gunduz M., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.25, sa.4, ss.236-244, 2015 (SCI-Expanded)
2014
2014Therapeutic plasmapheresis in geriatric patients: Favorable results
Ataca P., Marasuna O. A., Ayyildiz E., BAY M., İLHAN .
Transfusion and Apheresis Science
, cilt.51, sa.3, ss.64-67, 2014 (SCI-Expanded)
2014
2014Şiddetli Kardiyak Allogreft Rejeksiyonu Olan Bir Hastada Ekstrakorporeal Fotoferez Sonrası Quilty Etkisi
ÖZCAN Ö. U., SAYIN T., SÖĞÜT G., HEPER A., GÖKSÜLÜK H., VURGUN V. K., et al.
Turkish Journal of Hematology
, cilt.31, sa.4, ss.90-91, 2014 (SCI-Expanded)
2014
2014Ibrutinib: From Molecule to Medicine
AYYILDIZ O., DEMİRKAN F., GÖKER H., HAZNEDAROĞLU İ. C., İLHAN O., KAYNAR L. G., et al.
Uluslararası Hematoloji-Onkoloji Dergisi
, cilt.253, ss.4-14, 2014 (SCI-Expanded)
2014
2014The treatment of acquired hemophilia with combination therapy of immunosuppressives and immunoadsorption Kazani{dotless}lmi{dotless}ş hemofilinin immunsupresif ve immunadsorbsiyon kombinasyonu ile tedavisi
Bilgin A. U., ÖZCAN M., Ayyildiz E., İLHAN .
Turkish Journal of Hematology
, cilt.31, sa.2, ss.194-196, 2014 (SCI-Expanded)
2014
2014Ibrutinib: From Molecule to Medicine İbrutinib: Molekülden İlaca
Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., İLHAN ., KAYNAR L., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded)
2014
2014Quilty effect after extracorporeal photopheresis in a patient with severe refractory cardiac allograft rejection Şiddetli Kardiyak Allogreft Rejeksiyonu Olan Bir Hastada Ekstrakorporeal Fotoferez Sonrası Quilty Etkisi
Özcan Ö. U., SAYIN T., Soğut G., HEPER A., Göksülük H., Vurgun V. K., et al.
Turkish Journal of Hematology
, cilt.31, sa.4, ss.430-431, 2014 (SCI-Expanded)
2013
2013RHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients
Erkmen Uyar M., TOPRAK S. K., Saglam H., Tutal E., BAY M., İLHAN ., et al.
The Scientific World Journal
, cilt.2013, 2013 (SCI-Expanded)
2013
2013Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever
MEÇO B. C., MEMİKOĞLU K. O., İLHAN ., Ayyildiz E., Gunt C., ÜNAL M. N., et al.
Transfusion and Apheresis Science
, cilt.48, sa.3, ss.331-334, 2013 (SCI-Expanded)
2013
2013Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis
Kaya E., Keklik M., Şencan M., Yilmaz M., Keskin A., Kiki I., et al.
Transfusion and Apheresis Science
, cilt.48, sa.3, ss.349-352, 2013 (SCI-Expanded)
2013
2013Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study
Korkmaz S., Keklik M., Sivgin S., Yildirim R., Tombak A., Kaya M. E., et al.
Transfusion and Apheresis Science
, cilt.48, sa.3, ss.353-358, 2013 (SCI-Expanded)
2013
2013Review of therapeutic options and the management of patients with myelodysplastic syndromes
Özcan M. A., İLHAN ., Ozcebe O. I., Nalcaci M., Gülbas Z.
Expert Review of Hematology
, cilt.6, sa.2, ss.165-189, 2013 (SCI-Expanded)
2013
2013Turkish chronic myeloid leukemia study: Retrospective sectional analysis of CML patients
ŞAHİN F., SAYDAM G., CÖMERT M., UZ B., YAVUZ A. S., TURAN E., et al.
Turkish Journal of Hematology
, cilt.30, sa.4, ss.351-358, 2013 (SCI-Expanded)
2013
2013İnflamatuvar barsak hastalıklarında adzorptif lökositaferez uygulaması: İlk sonuçlarımız oldukça cesaret verici
TÖRÜNER M., TOPRAK S. K., MIZRAK K., YILDIRIM Y., BAY M., AYYILDIZ E., et al.
Turkish Journal of Hematology
, cilt.30, sa.2, ss.219-220, 2013 (SCI-Expanded)
2013
2013Adsorptive leukocytapheresis in inflammatory bowel diseases: Our preliminary results are encouraging İnfl amatuvar Barsak Hastalıklarında Adzorptif Lo̧kositaferez Uygulamas?: Ïlk Sonuçlarımız Oldukça Cesaret Verici
TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., BAY M., Ayyildiz E., et al.
Turkish Journal of Hematology
, cilt.30, sa.2, ss.219-220, 2013 (SCI-Expanded)
2012
2012Older age and capacity of colony forming unit in autologous peripheral derived hematopoietic cells
Civriz Bozdag S., BAY M., Ayyildiz E., TOPÇUOĞLU P., İLHAN .
Transfusion and Apheresis Science
, cilt.47, sa.1, ss.113-116, 2012 (SCI-Expanded)
2012
2012Plerixafor use in patients with previous mobilization failure: A multicenter experience
Tekgündüz E., Altuntaş F., Şivgin S., Aki Ş. Z., Dönmez A., Topçuoĝlu P., et al.
Transfusion and Apheresis Science
, cilt.47, sa.1, ss.77-80, 2012 (SCI-Expanded)
2012
2012Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products
Civriz Bozdag S., BAY M., Ayyildiz E., TOPÇUOĞLU P., İLHAN .
Transfusion and Apheresis Science
, cilt.47, sa.1, ss.117-120, 2012 (SCI-Expanded)
2012
2012Turkish Apheresis Activity for 2011
ALTUNTAŞ F., Unal A., İLHAN .
Transfusion and Apheresis Science
, cilt.47, sa.1, ss.57-58, 2012 (SCI-Expanded)
2012
2012Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients
TOPÇUOĞLU P., Arat M., ÖZCAN M., ARSLAN Ö., İLHAN ., Beksac M., et al.
Annals of Hematology
, cilt.91, sa.4, ss.577-586, 2012 (SCI-Expanded)
2011
2011Therapeutic plasma exchange in an intensive care unit (ICU): A 10-year, single-center experience
OZANSOY A., CAN Ö., Oral M., ÜNAL M. N., Ayyildiz E., İLHAN ., et al.
Transfusion and Apheresis Science
, cilt.45, sa.2, ss.161-166, 2011 (SCI-Expanded)
2011
2011The management of Chronic Myeloid Leukemia in the era of second generation tyrosine kinase Inhibitors
HAZNEDAROĞLU İ. C., Cetiner M., İLHAN .
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.21, sa.2 SUPPL. 1, ss.1-3, 2011 (SCI-Expanded)
2011
2011Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial
Beksac M., Ali R., Ozcelik T., ÖZCAN M., Ozcebe O., BAYIK M. M., et al.
Leukemia Research
, cilt.35, sa.3, ss.340-345, 2011 (SCI-Expanded)
2010
2010The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment
Sari T., YÜKSEL M., TOPÇUOĞLU P., BAY M., Ayyildiz E., ÖZCAN M., et al.
Transfusion and Apheresis Science
, cilt.43, sa.3, ss.315-320, 2010 (SCI-Expanded)
2010
2010Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy
ŞANLI H., AKAY B. N., Ayyildiz E., Anadolu R., İLHAN .
Transfusion and Apheresis Science
, cilt.43, sa.3, ss.353-359, 2010 (SCI-Expanded)
2010
2010Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
Gupta V., Eapen M., Brazauskas R., Carreras J., Aljurf M., Gale R. P., et al.
Haematologica
, cilt.95, sa.12, ss.2119-2125, 2010 (SCI-Expanded)
2010
2010Chronic myeloid leukemia: Practical issues in diagnosis, treatment and follow-up
Buyukasik Y., Haznedaroglu I. C., İLHAN .
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.20, sa.2 SUPPL., ss.1-12, 2010 (SCI-Expanded)
2010
2010Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
Shaughnessy P., Bolwell B., Van Besien K., Mistrik M., Grigg A., Dodds A., et al.
Bone Marrow Transplantation
, cilt.45, sa.6, ss.1068-1076, 2010 (SCI-Expanded)
2010
2010Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: A prospective randomized study
Koruk S., Mizrak A., Kaya Ugur B., İLHAN ., Baspinar O., Oner U.
Clinical Therapeutics
, cilt.32, sa.4, ss.701-709, 2010 (SCI-Expanded)
2010
2010The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: A pilot study
YÜKSEL M., TOPÇUOĞLU P., Kurdal M., İLHAN .
Cytotherapy
, cilt.12, sa.1, ss.38-44, 2010 (SCI-Expanded)
2009
2009Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: A randomized evaluation of early vs late administration of recombinant human G-CSF
Ozcelik T., TOPÇUOĞLU P., Beksac M., ÖZCAN M. E., Arat M., Bykl Z., et al.
Bone Marrow Transplantation
, cilt.44, sa.12, ss.779-783, 2009 (SCI-Expanded)
2009
2009Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia
Sayitoglu M., Haznedaroǧlu I. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.
Journal of International Medical Research
, cilt.37, sa.4, ss.1018-1028, 2009 (SCI-Expanded)
2009
2009Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma
Fenske T. S., Hari P. N., Carreras J., Zhang M., Kamble R. T., Bolwell B. J., et al.
Biology of Blood and Marrow Transplantation
, cilt.15, sa.11, ss.1455-1464, 2009 (SCI-Expanded)
2008
2008Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia
Lee S. J., Kukreja M., Wang T., Giralt S. A., Szer J., Arora M., et al.
Blood
, cilt.112, sa.8, ss.3500-3507, 2008 (SCI-Expanded)
2008
2008A case report of the Modified Malmö Protocol: An alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura
Yazman D., Konuk N., ÖZCAN M., Arat M., SOYDAN E., ARSLAN Ö., et al.
Therapeutic Apheresis and Dialysis
, cilt.12, sa.3, ss.255-258, 2008 (SCI-Expanded)
2008
2008Vitiligo after hematopoietic cell transplantation: Six cases and review of the literature
ŞANLI H., AKAY B. N., Arat M., KOÇYİĞİT P., Akan H., Beksac M., et al.
Dermatology
, cilt.216, sa.4, ss.349-354, 2008 (SCI-Expanded)
2008
2008HLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between the German AML Intergroup and CIBMTR
Schlenk R. F., Pasquini M. C., Pérez W. S., Zhang M., Krauter J., Antin J. H., et al.
Biology of Blood and Marrow Transplantation
, cilt.14, sa.2, ss.187-196, 2008 (SCI-Expanded)
2008
2008Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: An ex vivo experimental study
BAY M., AKAR A. R., Durdu S., Ayyildiz E., İLHAN .
Cytotherapy
, cilt.10, sa.1, ss.98-99, 2008 (SCI-Expanded)
2007
2007Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26)
Akalin I., KUTLAY N., İLHAN ., Tukun A.
International Journal of Laboratory Hematology
, cilt.29, sa.3, ss.215-220, 2007 (SCI-Expanded)
2007
2007How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight
TOPÇUOĞLU P., SOYDAN E., Ekiz F., Ayyildiz E., DALVA K., ÖZCAN M., et al.
Transfusion and Apheresis Science
, cilt.36, sa.3, ss.275-280, 2007 (SCI-Expanded)
2007
2007Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra
SOYDAN E., Ayyildiz E., DALVA K., TOPÇUOĞLU P., BAY M., ARSLAN Ö., et al.
Transfusion and Apheresis Science
, cilt.36, sa.3, ss.269-273, 2007 (SCI-Expanded)
2007
2007The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)
Ayyildiz E., ARSLAN Ö., TOPÇUOĞLU P., Arat M., DALVA K., SOYDAN E., et al.
Transfusion and Apheresis Science
, cilt.36, sa.1, ss.79-85, 2007 (SCI-Expanded)
2007
2007Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases
YÜCESAN C., Arslan Ö., Arat M., Yücemen N., Ayyildiz E., İLHAN ., et al.
Transfusion and Apheresis Science
, cilt.36, sa.1, ss.103-107, 2007 (SCI-Expanded)
2007
2007Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates
Büyükkaǧnici D. I., İLHAN ., Kavas G. Ö., ARSLAN Ö., Arat M., DALVA K., et al.
Transfusion and Apheresis Science
, cilt.36, sa.1, ss.73-78, 2007 (SCI-Expanded)
2006
2006Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?
Bakanay S. M., DALVA K., Arat M., ARSLAN Ö., Ayyildiz E., Beksac M., et al.
Transfusion and Apheresis Science
, cilt.34, sa.2, ss.171-178, 2006 (SCI-Expanded)
2006
2006Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission
Tallman M. S., Pérez W. S., Lazarus H. M., Gale R. P., Maziarz R. T., Rowe J. M., et al.
Biology of Blood and Marrow Transplantation
, cilt.12, sa.2, ss.204-216, 2006 (SCI-Expanded)
2005
2005Expression of IFITM1 in chronic myeloid leukemia patients
Akyerli C. B., Beksac M., Holko M., Frevel M., DALVA K., Özbek U., et al.
Leukemia Research
, cilt.29, sa.3, ss.283-286, 2005 (SCI-Expanded)
2004
2004High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation
DEMİRER T., Ayli M., Fen T., ÖZCAN M. E., Arat M., Buyukberber S., et al.
Bone Marrow Transplantation
, cilt.34, sa.9, ss.781-786, 2004 (SCI-Expanded)
2004
2004Transfusion and Apheresis Science: Introduction
İLHAN .
Transfusion and Apheresis Science
, cilt.30, sa.3, ss.179-180, 2004 (SCI-Expanded)
2004
2004Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease
İLHAN ., Arat M., ARSLAN Ö., Ayyildiz E., Sanli H., Beksac M., et al.
Transfusion and Apheresis Science
, cilt.30, sa.3, ss.185-187, 2004 (SCI-Expanded)
2004
2004Therapeutic plasma exchange in a single center: Ibni Sina experience
ARSLAN Ö., Arat M., Tek I., Ayyildiz E., İLHAN .
Transfusion and Apheresis Science
, cilt.30, sa.3, ss.181-184, 2004 (SCI-Expanded)
2004
2004Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience
Arat M., ARSLAN Ö., Ayyildiz E., TOPÇUOĞLU P., DALVA K., İLHAN .
Transfusion and Apheresis Science
, cilt.30, sa.3, ss.189-191, 2004 (SCI-Expanded)
2004
2004Simultaneous Onset of Chronic Graft Versus Host Disease and Alopecia Areata Following Allogeneic Haematopoietic Cell Transplantation [11]
ŞANLI H., Kusak F., Arat M., Ekmekci P., İLHAN .
Acta Dermato-Venereologica
, cilt.84, sa.1, ss.86-87, 2004 (SCI-Expanded)
2004
2004Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure
Tek I., ARSLAN Ö., Arat M., Ayyildiz E., BAY M., Oral M., et al.
Transfusion and Apheresis Science
, cilt.31, sa.2, ss.89-93, 2004 (SCI-Expanded)
2004
2004The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy
Arat M., ARSLAN Ö., Gürman G., DALVA K., ÖZCAN M., Uǧur A., et al.
Transfusion and Apheresis Science
, cilt.30, sa.1, ss.9-15, 2004 (SCI-Expanded)
2003
2003The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia
KUTLAY S., Beksac M., DALVA K., İLHAN ., Koc H., Akan H., et al.
Leukemia and Lymphoma
, cilt.44, sa.5, ss.791-795, 2003 (SCI-Expanded)
2003
2003High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: A retrospective evaluation
DEMİRER T., Uysal V., Ayli M., Genc Y., İLHAN ., Koc H., et al.
Bone Marrow Transplantation
, cilt.31, sa.9, ss.755-761, 2003 (SCI-Expanded)
2003
2003Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers
Beksac M., Çelebi H., Sargín D., Yalcin A., Topcuoglo P., Kalayoglu-Besisik S., et al.
Bone Marrow Transplantation
, cilt.31, sa.10, ss.897-904, 2003 (SCI-Expanded)
2003
2003Effects of replacement fluids on coagulation system used for therapeutic plasma exchange
Tek I., ARSLAN Ö., Arat M., ÖZCAN M., Akdaǧ B., İLHAN .
Transfusion and Apheresis Science
, cilt.28, sa.1, ss.3-7, 2003 (SCI-Expanded)
2003
2003Malpositioning of Hickman catheters, left versus right sided attempts
ÜNAL A. E., BAYAR S., Arat M., İLHAN .
Transfusion and Apheresis Science
, cilt.28, sa.1, ss.9-12, 2003 (SCI-Expanded)
2002
2002Severity of chronic graft-versus-host disease: Association with treatment-related mortality and relapse
Lee S. J., Klein J. P., Barrett A. J., Ringden O., Antin J. H., Cahn J., et al.
Blood
, cilt.100, sa.2, ss.406-414, 2002 (SCI-Expanded)
2002
2002An unusual presentation of plasma cell dyscrasias: Cardiac tamponade due to myelomatous infiltration
Arat M., Ulusoy V., DEMİRER T., Uysal A. V., ÖZCAN M., Dinçer S., et al.
Leukemia and Lymphoma
, cilt.43, sa.1, ss.145-148, 2002 (SCI-Expanded)
2002
2002A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters
DEMİRER T., Dagli M., İLHAN ., Ayli M., Haznedar R., Fen T., et al.
Bone Marrow Transplantation
, cilt.29, sa.11, ss.893-897, 2002 (SCI-Expanded)
2002
2002In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia
Üstün C., Beksac M., DALVA K., Koc H., Konuk N., İLHAN ., et al.
Medical Oncology
, cilt.19, sa.1, ss.59-67, 2002 (SCI-Expanded)
2001
2001Effects of DMSO on platelet functions and P-Selectin expression during storage
Cetin M., Eser B., Er Ö., ÜNAL A., KILIÇ E., Patiroglu T., et al.
Transfusion and Apheresis Science
, cilt.24, sa.3, ss.261-267, 2001 (SCI-Expanded)
2001
2001The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation
Gürman G., Dilek I., ARSLAN Ö., Arat M., Beksaç M., İLHAN ., et al.
Transfusion and Apheresis Science
, cilt.24, sa.1, ss.23-28, 2001 (SCI-Expanded)
2001
2001Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA.
Ustün C., Arat M., Celebi H., Akan H., İLHAN ., Ozçelik T., et al.
Haematologica
, cilt.86, sa.10, 2001 (SCI-Expanded)
2001
2001CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation
DEMİRER T., İLHAN ., Arat M., YAVUZ Y., ÖZCAN M. E., DALVA K., et al.
Journal of Clinical Apheresis
, cilt.16, sa.2, ss.67-73, 2001 (SCI-Expanded)
2001
2001Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue [4]
Arat M., İLHAN ., Iayan E. A., Çelebl H., Koç H., Akan H.
Blood
, cilt.98, sa.3, ss.892-893, 2001 (SCI-Expanded)
2001
2001Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies
Gürman G., Arat M., İLHAN ., Konuk N., Beksaç M., ÇELEBİ H., et al.
Cytotherapy
, cilt.3, sa.4, ss.253-260, 2001 (SCI-Expanded)
2001
2001Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation
ÖZCAN M. E., Üstün C., Akçağlayan E., Akan H., ARSLAN Ö., İLHAN ., et al.
Bone Marrow Transplantation
, cilt.27, sa.5, ss.499-505, 2001 (SCI-Expanded)
2000
2000Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-α-2a treatment
Beksa M., Arat M., Akan H., Ko H., İLHAN ., ÖZCAN M.
Cancer
, cilt.89, sa.7, ss.1474-1481, 2000 (SCI-Expanded)
2000
2000A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies
DEMİRER T., İLHAN ., Mandel N., Arat M., Günel N., ÇELEBİ H., et al.
Bone Marrow Transplantation
, cilt.25, sa.7, ss.697-703, 2000 (SCI-Expanded)
2000
2000Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: Experience of Ibni Sina Hospital
ARSLAN Ö., COŞKUN H., Arat M., ÇELEBİ H., ÖZCAN M. E., Gürman G., et al.
Bone Marrow Transplantation
, cilt.25, sa.12, ss.1229-1232, 2000 (SCI-Expanded)
2000
2000Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF
ARSLAN Ö., Akan H., Arat M., DALVA K., ÖZCAN M. E., Gurman G., et al.
Cytotherapy
, cilt.2, sa.4, ss.259-265, 2000 (SCI-Expanded)
1999
1999Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations [4] (multiple letters)
Reddy V., Khan S., Wingard J., Mehta P., Marsh J., Schrezenmeier H., et al.
Blood
, cilt.94, sa.5, ss.1833-1834, 1999 (SCI-Expanded)
1999
1999Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European blood and marrow transplant (EBMT) severe aplastic anaemia working party
Marsh J., Schrezenmeier H., Marin R., İLHAN ., Ljungman P., McCann S., et al.
Blood
, cilt.93, sa.7, ss.2191-2195, 1999 (SCI-Expanded)
1999
1999The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
İLHAN ., ARSLAN Ö., Arat M., Beksaç M., Akan H., Özean M., et al.
Transfusion Science
, cilt.20, sa.1, ss.69-71, 1999 (SCI-Expanded)
1999
1999Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe
Üstün C., İDİLMAN R., Gürman G., ÖZCAN M., AKYOL G., Akan H., et al.
Journal of Hepatology
, cilt.31, sa.2, ss.202-209, 1999 (SCI-Expanded)
1999
1999Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation
DEMİRER T., ÇELEBİ H., Arat M., Üstün C., DEMİRER S., Dilek I., et al.
Bone Marrow Transplantation
, cilt.24, sa.3, ss.335-337, 1999 (SCI-Expanded)
1998
1998Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells
ARSLAN Ö., Seferoǧlu A., Gürman G., İLHAN ., Koç H.
Haematologia
, cilt.29, sa.1, ss.47-50, 1998 (SCI-Expanded)
1998
1998Allogeneic peripheral blood stem cell transplantation in acute non- lymphoblastic leukemia
ARSLAN Ö., Üstün C., Arat M., Çelebi H., Akan H., Beksaç M., et al.
Hematological Oncology
, cilt.16, sa.4, ss.155-162, 1998 (SCI-Expanded)
1998
1998Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey
ARSLAN Ö., Gürman G., Dilek I., ÖZCAN M., Koç H., İLHAN ., et al.
Haematologia
, cilt.29, sa.1, ss.59-62, 1998 (SCI-Expanded)
1998
1998Serum erythropoietin levels in patients with leukemia on cytostatic treatment
Aydogdu I., İLHAN ., Beksac M., Koc H., Akan H., Konuk N., et al.
Haematologia
, cilt.29, sa.2, ss.133-137, 1998 (SCI-Expanded)
1998
1998Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia
Dilek I., DEMİRER T., Üstün C., Arat M., Koç H., Beksaç M., et al.
Bone Marrow Transplantation
, cilt.21, sa.11, ss.1159-1161, 1998 (SCI-Expanded)
1997
1997A case report of a patient who has pure red cell aplasia and rheumatoid arthritis
Üstün C., Karavelioǧlu D., İLHAN ., Aydintuǧ O., Beksaç M.
International Journal of Hematology
, cilt.66, sa.4, ss.505-512, 1997 (SCI-Expanded)
1997
1997Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma
Aydogdu I., Koc H., İLHAN ., Gurman G., Akan H., Beksac M., et al.
Haematologia
, cilt.28, sa.4, ss.207-213, 1997 (SCI-Expanded)
1997
1997Hepatitis B virus infection in allogeneic bone marrow transplantation
Üstün C., Koç H., Karayalçin S., AKYOL G., Gürman G., İLHAN ., et al.
Bone Marrow Transplantation
, cilt.20, sa.4, ss.289-296, 1997 (SCI-Expanded)
1997
1997Febrile neutropenia in a bone marrow transplantation unit
Akan H., Koç H., ARSLAN Ö., Beksaç M., İLHAN ., Gürman G., et al.
International Journal of Antimicrobial Agents
, cilt.8, sa.2, ss.127-130, 1997 (SCI-Expanded)
1997
1997Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support
Koç H., ARSLAN Ö., Gürman G., Akan H., ÖZCAN M., İLHAN ., et al.
Acta Haematologica
, cilt.98, sa.3, ss.136-139, 1997 (SCI-Expanded)
1997
1997Hemorrhagic cystitis as a complication of bone marrow transplantation
İLHAN ., Koç H., Akan H., Gürman G., ARSLAN Ö., ÖZCAN M. E., et al.
Journal of Chemotherapy
, cilt.9, sa.1, ss.56-61, 1997 (SCI-Expanded)
1997
1997Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients?
Koç H., Gürman G., ARSLAN Ö., ÖZCAN M. E., Dilek I., Akan H., et al.
Journal of Chemotherapy
, cilt.9, sa.5, ss.371-376, 1997 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
2024
2024Lenfoplazmasitik Lenfomada Yeni Nesil Dizileme Yöntemiyle Mutasyon İncelemesinin Tanı ve Tedavi Planında Yeri
KOYUN D., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., TOPÇUOĞLU P., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, cilt.8, sa.1, ss.39-45, 2024 (Hakemli Dergi)
2023
2023Allojeneik Hematopoetik Kök Hücre Nakli Sonrası Aseptik Nekroz Gelişen Olgularda Vitamin D Reseptör Gen Polimorfizmi
SOYDAN E., ŞAHİN U., CEYLANER S., GÖKMEN A., DOĞAN H., OKCU M. K., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, cilt.7, sa.2, ss.51-56, 2023 (Hakemli Dergi)
2022
2022İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi
KIRCALI E., SEVAL G. C., ÖZTÜRK C., Yilmaz H., ŞENOYMAK M. C., ERMİŞ G. Y., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, cilt.6, sa.2, ss.50-55, 2022 (Hakemli Dergi)
2022
2022Lipoprotein apheresis efficacy and challenges: single center experience
Özdemir Z. N., Şahin U., Yıldırım Y., TULUNAY KAYA C., İLHAN .
Hematology, Transfusion and Cell Therapy
, cilt.44, sa.1, ss.56-62, 2022 (ESCI)
2021
2021Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings
Soto-Perez-de-Celis E., Martínez-Peromingo J., Chávarri-Guerra Y., Loh K. P., Demichelis-Gómez R., Rodrigues M., et al.
The Lancet Healthy Longevity
, cilt.2, sa.11, 2021 (ESCI)
2021
2021Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis
Karadag F. K., YENEREL M. N., YILMAZ M., uskudar T. H., ÖZKOCAMAN V., Tuglular T., et al.
American journal of Blood Research , cilt.11, sa.3, ss.279-285, 2021 (Hakemli Dergi)
2021
2021Relaps Refrakter Hodgkin Lenfomada Brentuksimab Vedotin Kullanımı: Tek Merkez Deneyimi
KOYUN D., SEVAL G. C., SÖKMEN M., AKKUŞ E., ATİLLA E., BOZDAĞ S. C., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, cilt.5, sa.1, ss.1-4, 2021 (Hakemli Dergi)
2021
2021Trombositozlu Olgularda Terapötik Trombosit Aferezinin Etkinliği
ÖZDEMİR Z. N., ŞAHİN U., BOZDAĞ S. C., YÜKSEL M. K., TOPRAK S. K., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası
, cilt.74, sa.3, ss.278-282, 2021 (Hakemli Dergi)
2020
2020Bir Nakil Merkezinin 11 YıllıkAllojeneik Kök Hücre Nakli Deneyimi
KIRCALI E., SEVAL G. C., BOZDAĞ S. C., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, cilt.4, sa.3, ss.50-54, 2020 (Hakemli Dergi)
2020
2020Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli
ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası
, cilt.73, sa.2, ss.113-117, 2020 (Hakemli Dergi)
2020
2020Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome
ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.2, ss.113-117, 2020 (Hakemli Dergi)
2020
2020Miyelodisplastik Sendrom HastalarınınAkan Hücre Ölçer ile Yapılan OgataSkorlaması Yoluyla Değerlendirilmesi:Pilot Çalışma
ATİLLA E., Kırcalı E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, cilt.4, sa.3, ss.45-49, 2020 (Hakemli Dergi)
2020
2020Our Approach in Allogeneic Stem CellTransplantation: 11 Years of Experience
Kırcalı E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.50-54, 2020 (Hakemli Dergi)
2020
2020Evaluation of Patients With Myelodysplastic Syndromeby Ogata Scoring in Flow Cytometry: Pilot Study
ATİLLA E., Kırcalı E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.45-49, 2020 (Hakemli Dergi)
2020
2020Our Treatment Approach to Hairy Cell Leukemia
ATACA ATİLLA P., ATİLLA E., KIRCALI E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (Hakemli Dergi)
2020
2020Tüylü Hücreli Lösemide Tedavi Yaklaşımımız
ATACA ATİLLA P., ATİLLA E., Kırcalı E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası
, cilt.73, sa.1, ss.5-8, 2020 (Hakemli Dergi)
2019
2019Impact of Hepatitis B Core Antibody Seropositivity on the Liver Function Tests After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.3, ss.55-59, 2019 (Hakemli Dergi)
2019
2019MULTİPLE MYELOMA HASTALARINDA ORTA DOZ SİKLOFOSFOMİD (2.5g /m2 Cy) İLE HEMATOPOETİK KÖK HÜCRE MOBİLİZASYONU SONUÇLARIMIZ
GÖKGÖZ Z., SOYDAN E., GÖKMEN A., İLHAN O., ARSLAN Ö., ÖZCAN M.
İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi
, cilt.23, sa.3, ss.184-189, 2019 (Hakemli Dergi)
2019
2019Akut Lösemide Allojeneik Nakil Öncesi Serum Ferritin Düzeyinin Nakil Sonuçlarına Etkisi
ŞAHİN U., HASAN E., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.1, ss.1-3, 2019 (Hakemli Dergi)
2019
2019The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia
ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.1, ss.9-13, 2019 (Hakemli Dergi)
2018
2018Kronik Lenfositik Lösemi’de Tanı Anında Hipogammaglobulinemi Sağkalım ve Enfeksiyon Riski Üzerine Etklili Midir?
ATİLLA E., Özel F., ATACA ATİLLA P., TOPÇUOĞLU P., AKAN H., BEKSAÇ M., et al.
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
, cilt.20, sa.3, 2018 (Hakemli Dergi)
2018
2018Primer Mediastinal Büyük B Hücreli Lenfoma Hastalarımızın Tedavi Sonuçlarının Geriye Dönük Değerlendirilmesi
ATİLLA E., ATACA ATİLLA P., CENGİZ SEVAL G., TOPRAK S. K., İLHAN O., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.3, 2018 (Hakemli Dergi)
2018
2018KRONİK LENFOSİTİK LÖSEMİ’DE TANI ANINDAHİPOGAMMAGLOBULİNEMİSAĞKALIM VE ENFEKSİYON RİSKİ ÜZERİNDE ETKİLİ MİDİR?
ATİLLA E., ÖZEL F., ATACA ATİLLA P., TOPÇUOĞLU P., AKAN H., BEKSAÇ M., et al.
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.294-299, 2018 (Hakemli Dergi)
2018
2018Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience af a Single Center
ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., DALVA K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.4, ss.93-97, 2018 (Hakemli Dergi)
2018
2018Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response
NARLI ÖZDEMİR Z., USLU A., TOPRAK S. K., TOPÇUOĞLU P., DALVA K., İLHAN O.
Hematological Disease and Therapies , 2018 (Hakemli Dergi)
2018
2018Kronik Lenfositik Lösemi’de Allojeneik Kök Hücre Nakli Deneyimi
ATİLLA E., PEKCAN G., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası
, cilt.71, sa.1, ss.43-46, 2018 (Hakemli Dergi)
2018
2018Allogeneic Stem Cell Transplantation Experience in Chronic Lymphocytic Leukemia
ATİLLA E., Pekca G., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.71, sa.1, ss.43-46, 2018 (Hakemli Dergi)
2018
2018Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience
Atilla P. A., Atilla E., Bozdag S. C., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
Hematology/ Oncology and Stem Cell Therapy
, cilt.11, sa.1, ss.13-17, 2018 (Scopus)
2018
2018Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea
ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , cilt.11, sa.1, ss.13-17, 2018 (Scopus)
2018
2018Multiple Arterial Thrombosis Related with Cantharidin Ingestion
NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., İLHAN O.
CASE REPORTS IN HEMATOLOGY
, cilt.2018, sa.8159093, ss.1-3, 2018 (Hakemli Dergi)
2017
2017Clinical characteristics and treatments outcomes in elderly patients with multiple myeloma: A multicenter retrospective study
TERZİ H., KORKMAZ S., BERBER İ., KEKLİK M., DOĞU M. H., ŞENCAN M., et al.
Cumhuriyet Tıp Dergisi (ELEKTRONİK)
, cilt.39, sa.1, ss.389-395, 2017 (Hakemli Dergi)
2012
2012Kök hücre nakli hastalarında tamamlayıcı ve alternatif tedavi kullanımı
KARACAN Y., AKKUŞ Y., AKDEMİR N., GÖKER H., AKSU S., SUCAK A. G., et al.
Uludağ Üniversitesi Tıp Fakültesi Dergisi
, cilt.38, sa.1, ss.1-6, 2012 (Hakemli Dergi)
2010
2010The impact of levobupivagaine and bupivacaine on postoperative respiratory functions and pain management in thoracic epidural analgesia Bupivakain ve levobupivakain'in torakal epidural uygulamalarinda postoperatif solunum fonksiyonlari ve aǧri üzerine etkileri
Serin G., Göksu S., Koruk S., Şahin L., Gül R., İLHAN ., et al.
Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi
, cilt.16, sa.3, ss.96-102, 2010 (Scopus)
2010
2010Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
ŞANLI H., AKAY B. N., SOYDAN E., KOÇYİĞİT P., ARAT M., İLHAN O.
Turkish Journal of Hematology
, cilt.27, sa.2, ss.91-98, 2010 (Scopus)
2010
2010Dexmedetomidine in the supratentorial craniotomy
İLHAN O., KORUK S., SERİN G., ERKUTLU İ., ÖNER Ü.
Eurasian Journal of Medicine
, cilt.42, sa.2, ss.61-65, 2010 (Hakemli Dergi)
2010
2010Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation Allogeneik hematopoietik hücre nakli sonrası sklerodermatoz tip graft-versus-host hastalıǧının klinik yönleri
ŞANLI H., AKAY B. N., SOYDAN E., KOÇYİĞİT P., Arat M., İLHAN .
Turkish Journal of Hematology
, cilt.27, sa.2, ss.91-98, 2010 (Scopus)
2009
2009Retrospective evaluation of patients treated with dasatinib for Philadelphia positive leukemias: Turkish experience of 16 months
Saydam G., Haznedaroglu I. C., Temiz Y., Soysal T., Sucak G., Tombuloglu M., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.19, sa.4, ss.195-204, 2009 (Scopus)
2008
2008Clonal evolution of monosomy 7 in acquired severe aplastic anemia: Two cases treated with allogeneic hematopoietic stem cell transplantation
Bakanay Ş. M., TOPÇUOĞLU P., Bilgin A. U., Yararbaş K., Karaüzüm S. B., ÖZCAN M., et al.
Turkish Journal of Hematology
, cilt.25, sa.2, ss.94-97, 2008 (Scopus)
2008
2008Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience
İLHAN ., TOPÇUOĞLU P., Arat M., SOYDAN E., YÜKSEL M., ARSLAN Ö., et al.
Turkish Journal of Hematology
, cilt.25, sa.2, ss.87-93, 2008 (Scopus)
2004
2004Therapeutic angiogenesis by autologous transplantation of bone-marrow mononuclear cells for Buersger's patients with retractable limb ischaemia: A preliminary report
AKAR A. R., Durdu S., Arat M., Eren N. T., ARSLAN Ö., Çorapçioǧlu T., et al.
Turkish Journal of Haematology
, cilt.21, sa.1, ss.13-21, 2004 (Scopus)
2004
2004Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange
ARSLAN Ö., Tek I., Arat M., ÇİFTCİ İ., İLHAN .
Therapeutic Apheresis and Dialysis
, cilt.8, sa.2, ss.144-147, 2004 (Scopus)
2003
2003Autologous platelet collection and storage to support thrombocytopenia in a leukemia patient with platelet alloimmunization undergoing chemotherapy
YÜKSEL M., Arat M., ARSLAN Ö., Beksaç M., İLHAN .
Turkish Journal of Haematology
, cilt.20, sa.4, ss.233-236, 2003 (Scopus)
2003
2003Clinical use of erythropoietin in patients with anemia due to radiotherapy Radyoterapi̇ alan anemi̇k hastalarda eri̇tropoeti̇n'i̇n kli̇ni̇k kullanimi
ALTUNTAŞ F., Arat M., İLHAN .
Erciyes Tip Dergisi
, cilt.25, sa.1, ss.45-53, 2003 (Scopus)
2003
2003Therapeutic plasma exchange and the clinical applications
ARSLAN Ö., Arat M., Göktürk S., Ayyildiz E., İLHAN .
Turkish Journal of Haematology
, cilt.20, sa.1, ss.7-17, 2003 (Scopus)
2002
2002Extramedullary presentation of biclonal IgGκ and IgAκ multiple myeloma
Alanoǧlu G., Özet G., DALVA K., KUZU I., Erekul S., İLHAN ., et al.
Turkish Journal of Haematology
, cilt.19, sa.3, ss.421-425, 2002 (Scopus)
2002
2002The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation
ARSLAN Ö., Coşkun H. Ş., Arat M., SOYDAN E., ÖZCAN M., Gürman G., et al.
Turkish Journal of Haematology
, cilt.19, sa.3, ss.401-409, 2002 (Scopus)
2002
2002Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield
DEMİRER T., İLHAN ., Ayli M., Arat M., Dagli M., ÖZCAN M., et al.
Therapeutic Apheresis
, cilt.6, sa.5, ss.384-389, 2002 (Scopus)
2002
2002Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers
KUTLAY S., İLHAN ., ARSLAN Ö., Beksac M.
Therapeutic Apheresis
, cilt.6, sa.1, ss.82-85, 2002 (Scopus)
2002
2002A case of catheter related septicemia caused by Corynebacterium jeikeium
Arikan Akan Ö., Bengisun J. S., Bati A., Arat M., İLHAN ., Akan H.
Turkish Journal of Haematology
, cilt.19, sa.1, ss.47-50, 2002 (Scopus)
2001
2001Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia
Gürman G., ÇELEBİ H., Üstün C., Arat M., İLHAN ., ÖZCAN M. E., et al.
Therapeutic Apheresis
, cilt.5, sa.1, ss.54-57, 2001 (Scopus)
2001
2001Treatment of aplastic anemia: Experience of Ibn-i Sina Hospital
İLHAN ., Bakanay Ş., Arat M., ÖZCAN M. E., ÇELEBİ H., Gürman G., et al.
Turkish Journal of Haematology
, cilt.18, sa.1, ss.33-40, 2001 (Scopus)
2001
2001Multiple myeloma: Current approach Multi̇pl myeloma: Güncel yaklaşimlar
Coşkun H., Er Ö., İLHAN .
Erciyes Tip Dergisi
, cilt.23, sa.2, ss.83-90, 2001 (Scopus)
2001
2001Severe hypotensive reaction due to a bedside white cell reduction filter
ARSLAN Ö., Elkiran T., Arat M., İLHAN ., Koç H.
Turkish Journal of Haematology
, cilt.18, sa.1, ss.59-61, 2001 (Scopus)
2000
2000The incidence of Hepatitis G virus in patients with hematological malignancies: The relationship to the number of blood and blood products transfusions
Idilman R., Ustun C., Aslan O., Ozcan M., Arat M., Bozkaya H., et al.
Turkish Journal of Haematology
, cilt.17, sa.2, ss.67-71, 2000 (Scopus)
2000
2000National survey of hemapheresis practice in Turkey (1998)
İLHAN ., üskent N., ARSLAN Ö., Arat M., ÖZKALEMKAŞ F., öztürk G., et al.
Transfusion and Apheresis Science
, cilt.22, sa.3, ss.195-201, 2000 (Scopus)
2000
2000Immunosuppressive therapy-induced hepatotoxicity in patients with aplastic anemia
Dilek I., İDİLMAN R., Fenkci S., Ustun C., Koc H., İLHAN ., et al.
Turkish Journal of Haematology
, cilt.17, sa.3, ss.111-117, 2000 (Scopus)
1999
1999Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report
Üstün C., Çelebi H., Arat M., ÖZCAN M., Dilek I., Gürman G., et al.
Therapeutic Apheresis
, cilt.3, sa.3, ss.275-277, 1999 (Scopus)
1999
1999Differences in liver pathology and clinical outcome between two patients with Hepatitis B virus and graft versus host disease
Üstün C., ÖZCAN M., Gürman G., Çakir M., Erekul S., AKYOL G., et al.
Pathology and Oncology Research
, cilt.5, sa.3, ss.229-232, 1999 (Scopus)
1998
1998Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia
Beksaç M., ARSLAN Ö., Koç H., Akan H., İLHAN ., Arat M., et al.
Medical Oncology
, cilt.15, sa.3, ss.183-190, 1998 (Scopus)
1997
1997Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey
İLHAN ., Akan H., Koç H., Gürman G., ARSLAN Ö., ÖZCAN M. E., et al.
Hematology and Cell Therapy
, cilt.39, sa.3, ss.133-136, 1997 (Scopus)
1997
1997Evaluation of saturation index of lymphoma patients
ÇOK İ., Karakaya A., Sardas S., İLHAN ., Koc H.
Gazi Universitesi Eczacilik Fakultesi Dergisi
, cilt.14, sa.1, ss.5-10, 1997 (Scopus)
1996
1996Administration of mine protocol in intermediate and high grade non- Hodkin's lymphomas Primejena Protokola mine u lijecenju nehodgikinovih limfona srednjeg i visokog stupnja
Aydogdu I., Koc H., İLHAN ., Gurman G., Akan H., Beksac M., et al.
Libri Oncologici
, cilt.25, sa.2-3, ss.103-106, 1996 (Scopus)
1996
1996Lack of prognostic value of CD34 in adult AML.
Arslan O., Akan H., Beksac M., Ozcan M., Koc H., İLHAN ., et al.
Leukemia & lymphoma
, cilt.23, sa.1-2, ss.185-186, 1996 (Scopus)
1996
1996Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation? [6]
Koc H., Gurman G., ARSLAN Ö., ÖZCAN M. E., Akan H., İLHAN ., et al.
Blood
, cilt.88, sa.6, ss.2362-2364, 1996 (Scopus)
1995
1995A single center randomized study comparing the efficacy of sulbactam/cefoperazone + amikacin vs ceftazidim + amikacin in febrile neutropenic patients FEBRIL NOTROPENIK HASTALARDA TEK MERKEZLI RANDOMIZE BIR CALISMADA SULBAKTAM/SEFOPERAZON + AMIKASIN ILE SEFTAZIDIM + AMIKASIN ETKINLIGININ KARSILASTIRILMASI
Akan H., Koc H., Aydogdu I., İLHAN ., Beksac M., Gurman G., et al.
Mikrobiyoloji Bulteni
, cilt.29, sa.2, ss.131-135, 1995 (Scopus)
1995
1995HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy [4]
İLHAN ., Beksac M., Koc H., Akan H., Keskin A., ARSLAN Ö., et al.
Blood
, cilt.86, sa.5, ss.2055, 1995 (Scopus)
1995
1995Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia [1]
Gurman G., Kahveci G., Akan H., İLHAN ., Koc H., Beksac M., et al.
Bone Marrow Transplantation
, cilt.15, sa.3, ss.485-486, 1995 (Scopus)
1995
1995P53 codon 213 (a-g) polymorphism in a turkish population
Ilhan I., Erekul S., Ateşalp S., İLHAN ., Akar N.
Pediatric Hematology and Oncology
, cilt.12, sa.5, ss.499-501, 1995 (Scopus)
1994
1994Terminal deoxynucleotidyl transferase (TdT) positivity in acute nonlymphoblastic leukemia [1]
ARSLAN Ö., Akan H., Beksac M., İLHAN ., Koc H., Konuk N.
Leukemia
, cilt.8, sa.6, ss.1067, 1994 (Scopus)
1994
1994Relevance of serum G-CSF levels in bone marrow transplantation patients [1]
Beksac M., ÖZCAN M. E., Koc H., Akan H., İLHAN .
Experimental Hematology
, cilt.22, sa.6, ss.480-481, 1994 (Scopus)
1994
1994Peripheral T cell receptors αβ, and γδ in patients with Hodgkin's lymphoma
Akan H., Beksac M., Aydogdu I., Koc H., İLHAN ., Ozcan M.
British Journal of Haematology
, cilt.87, sa.3, ss.544-547, 1994 (Scopus)
1993
1993Cyclosporin A (CsA) + methylprednisone (MP) and antilymphocyte globulin + methylprednisone (MP) therapy in patients with aplastic anemia: Ibn-i Sina Hospital experience
İLHAN ., Koc H., Beksac M., Akan H., Aydogdu I., Konuk N., et al.
Bulletin of Gulhane Military Medical Academy
, cilt.35, sa.4, ss.893-897, 1993 (Scopus)
1993
1993The clinical correlations of serum tumor necrosis factor-alpha in acute leukemias: A predictor of response and relapse?
Beksaç M., ERTÜRK Ş., Akan H., Koç H., İLHAN .
Leukemia
, cilt.7, sa.11, ss.1773-1776, 1993 (Scopus)
1992
1992Circulating endogenous granulocyte colony-stimulating factor levels after bone marrow transplantation [4]
Beksac M., ÖZCAN M. E., Koc H., Akan H., İLHAN ., Sardas O., et al.
Blood
, cilt.80, sa.11, ss.2946-2947, 1992 (Scopus)
1991
1991Use of high dose chemotherapy and autologous bone marrow transplantation in patients with intermediate or high grade NHL both as a consolidation after remission or in early relapse
Sardas O., Koc H., İLHAN ., Akan H., Beksac M.
Istanbul Tip Fakultesi Mecmuasi
, cilt.54, sa.4, ss.567-574, 1991 (Scopus)
1990
1990Tumor necrosis factor α in human bone marrow recipients
Sardas O., Beksac M., Koc H., İLHAN ., Akan H., Gurman G.
Blood
, cilt.76, sa.12, ss.2639, 1990 (Scopus)
1990
1990Polymorphic N‐acetylation capacity in breast cancer patients
Şardş S., ÇOK İ., Seyfişardaş O., İLHAN ., Karakaya A. E.
International Journal of Cancer
, cilt.46, sa.6, ss.1138-1139, 1990 (Scopus)
1990
1990Hepatic failure after bone marrow transplantation (I)
Sardas O., Koc H., İLHAN ., Akan H., Beksac M.
Blood
, cilt.75, sa.11, ss.2265, 1990 (Scopus)
1977
1977A meningococcal epidemic in Ankara Ankara ilinde devam etmekte olan menengokoksk menenjit salgini.
Berkman E., Ozben G., İLHAN .
Mikrobiyoloji Bulteni
, cilt.11, sa.2, ss.256-266, 1977 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2021
2021the impact of pretransplant ımmunomodulatory drugs on cmv reactıvatıon
YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., YAVUZ G., et al.
8th International Congress on Leukemia Lymphoma Myeloma, 10 Ocak 2021, (Tam Metin Bildiri)
2021
2021PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION
KIRCALI E., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
8th International Congress on Leukemia Lymphoma Myeloma, 21 Mayıs 2021, (Tam Metin Bildiri)
2020
2020TİROZİN KİNAZ İNHİBİTÖRLERİNİ KESME KARARINDA KEMİKİLİĞİNDEKİ LÖSEMİK KÖK HÜCRE VARLIĞININ ÖNEMİ
İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.
46. Ulusal Hematoloji Kongresi, Türkiye, 28 - 31 Ekim 2020, (Özet Bildiri)
2020
2020DECISION TO STOP TYROSINE KINASE INHIBITORS (TKIS) WITH BONE MARROW LEUKEMIC STEM CELL LEVEL: DETECTION OF BCR-ABL IN PERIPHERAL BLOOD MAY NOT BE ENOUGH
İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.
25th European Hematology Congress Virtual, 11 - 21 Haziran 2020, (Özet Bildiri)
2020
2020Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience
DEMİRER T., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 29 Mayıs - 02 Haziran 2020, cilt.38, ss.19522, (Tam Metin Bildiri)
2020
2020A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm
ÖZCAN M., KOYUN D., CENGİZ SEVAL G., USLU A., KIRCALİ E., ÖZTÜRK C., et al.
2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 29 Mayıs - 02 Haziran 2020, (Tam Metin Bildiri)
2020
2020Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis
CENGİZ SEVAL G., Öztürk N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Orlando, Amerika Birleşik Devletleri, 19 - 23 Şubat 2020, cilt.26, ss.109-110, (Tam Metin Bildiri)
2020
2020Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease
İLHAN O., Seval G. C., UZAY A., KAYA E., Öztürk Z. N., DEVECİ B., et al.
Transplantation Cellular Therapy Meetings of ASTCT and CIBMTR, Amerika Birleşik Devletleri, 8 - 12 Şubat 2020, cilt.26, ss.191, (Tam Metin Bildiri)
2019
2019Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions
Pierre F., Ghulam J. M., Rena J B., Valeria S., Mara Dez C., Carlo F., et al.
ASH 2019, 7 - 10 Aralık 2019
2019
2019Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data
CENGİZ SEVAL G., USLU A., KIRCALI E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.
ASH 2019, 7 - 10 Aralık 2019, (Özet Bildiri)
2019
2019Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?
KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
ASH 2019, 7 - 10 Aralık 2019, (Özet Bildiri)
2019
2019Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Final Results from the Phase IIIb GREEN Safety Study with a Focus on Efficacy
Stephan S., Bosch F., Vronique L., İLHAN O., Jens K., Batrice M., et al.
ASH 2019, 7 - 10 Aralık 2019, (Tam Metin Bildiri)
2019
2019Hematologic Improvement–Neutrophil and –Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions
Guillermo G., hulam J. M., Pierre F., Valeria S., Mara Dez C., Carlo F., et al.
ASH2019, 7 - 10 Aralık 2019, (Tam Metin Bildiri)
2019
2019Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis
CENGİZ SEVAL G., ÖZTÜRK N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
ASH 2019, 7 - 10 Aralık 2019, (Özet Bildiri)
2019
2019KRONİK MİYELOİD LOSEMİ (KML) HASTALARINDA KML KOKHUCRESİ BCR- ABL’DEN BAĞIMSIZ PROGNOSTİK BİR FAKTOR OLABİLİR Mİ?
TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.
45. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)
2019
2019YENİ TANI KLL HASTALARINDA TANI SIRASINDAKİ CD49DEKSPRESYONUNUN HASTALIĞA OZGU BAŞKA PARAMETRELERLEİLİŞKİSİ
TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019, (Tam Metin Bildiri)
2019
2019Kronik Myeloid Lösemi (KML) Hastalarında KML Kök Hücresi BCR-ABL’ den Bağımsız Prognostik Bir Faktör Olabilir mi?
İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)
2019
2019YAŞAM SÜRESİNİ VE KALİTESİNİ ETKİLEYEN DİRENÇLİ KGVHH TEDAVİSİNDE YENİ BİR YAKLAŞIMBTK İNHİBİTÖRÜ:GERÇEK YAŞAM VERİSİ
İLHAN O., Seval G. C., UZAY A., KAYA E., DEVECİ B., YAVAŞOĞLU İ., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019, (Tam Metin Bildiri)
2019
2019TÜRKİYE’DE PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI
İLHAN O., ÖZDEMİR Z. N., ÖZET G., FALAY M., YENEREL M. N., TUĞLULAR A. T., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.131-132, (Tam Metin Bildiri)
2019
2019TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI
İLHAN O., NARLI ÖZDEMİR Z., ÖZET G., falay m., YENEREL M. N., TUĞLULAR A. T., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)
2019
2019A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)
BEKSAÇ M., CENGİZ SEVAL G., KOYUN D., TOPÇUOĞLU P., YÜKSEL M., GÜRMAN G., et al.
Lymphoma and Myeloma Congress 2019, 23 - 26 Ekim 2019, (Tam Metin Bildiri)
2019
2019Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation
CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
17th International Myeloma Workshop, 12 - 15 Eylül 2019, (Tam Metin Bildiri)
2019
2019Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions
İLHAN O., CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
45th Annual Meeting of the European Society for Blood and Marrow Transplantation, 24 - 27 Mart 2019, (Tam Metin Bildiri)
2019
2019Clonal Plasma Cell Detection by High Sensitive Flow Cytometry in Aphaeresis Product is Poor Prognostıc and not Increased by Use of Plerixafor Alone
CENGİZ SEVAL G., USLU A., DALVA K., BAKANAY S., MERTER M., ŞAHİN U., et al.
45th Annual Meeting of the European Society for Blood and Marrow Transplantation, Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.496-497, (Özet Bildiri)
2019
2019Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT
YÜKSEL M., CENGİZ SEVAL G., KİRCİLİ E., D, K., ÖZTÜRK C., NARLI ÖZDEMİR Z., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), 24 - 27 Mart 2019, (Tam Metin Bildiri)
2019
2019Is mobilization with chemotherapy effect response in the multiple myeloma?
CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.
45th Annual Meeting of the European Society for Blood and Marrow Transplantation, 24 - 27 Mart 2019, (Tam Metin Bildiri)
2019
2019Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?
YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
24th Congress of the European Hematology Association, 13 - 16 Haziran 2019, (Tam Metin Bildiri)
2019
2019Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?
İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 1 - 03 Haziran 2019, (Tam Metin Bildiri)
2019
2019Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation
DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 1 - 03 Haziran 2019, (Tam Metin Bildiri)
2019
2019Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.
DEMİRER T., SEVAL G. C., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
ASCO, 31 Mayıs - 03 Haziran 2019, (Tam Metin Bildiri)
2019
2019RETROSPECTIVE ANALYSIS OF 149 UNSELECTED PATIENTS WITH MANTLE CELL LYMPHOMA CONFIRMS PROGNOSTIC RELEVANCE OF MIPI: SINGLE CENTER EXPERIENCE
CENGİZ SEVAL G., ULAŞ B. B., Bolat B., Taşçı O., Karatepe F., KUZU I., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER
CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019PRE-TRANSPLANT HEMOGLOBIN AND SERUM CREATININE LEVELS CORRELATE WITH PROGRESSION FREE SURVIVAL IN MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019CAN ELTROMBOPAG TREAT THE THROMBCYTOPENIA AFTER STEM CELL TRANSPLANTATION
YÜKSEL M., KIRCALI E., CENGİZ SEVAL G., KOYUN D., USLU A., ÖZTÜRK C., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, (Özet Bildiri)
2019
2019LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTEMYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS -A RETROSPECTIVE STUDY FROM A TERTIARY CENTER
SEVAL G. C., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?
SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence
CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
ICLLM 2019, 02 Mayıs 2019, (Tam Metin Bildiri)
2019
2019RETROSPECTIVE ANALYSIS OF 149 UNSELECTED PATIENTSWITH MANTLE CELL LYMPHOMA CONFIRMS PROGNOSTICRELEVANCE OF MIPI: SINGLE CENTER EXPERIENCE
SEVAL G. C., ULAŞ B. B., bolat b., Taşçı O., karatepe f., KUZU I., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz
KIRCALİ E., CENGİZ SEVAL G., KOYUN D., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., ÖZCAN M., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)
2019
2019Multiple Myelom Hastalarında Otolog Periferik Kök Hücre Nakli Esnasında Gelişen Nötropenik Ateş
USLU A., CENGİZ SEVAL G., ÖZTÜRK C., NARLI ÖZDEMİR Z., KIRCALİ E., KOYUN D., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)
2019
2019Allojeneik Kök Hücre Nakli Sonrası Akut Lösemi Hastalarında Nüksü Öngörmede Kimerizm İle Mrd Karşılaştırılması
CENGİZ SEVAL G., ULAŞ B. B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)
2019
2019İyi Riskli Aml’de İkinci Tam Remisyonda Allojeneik Hematopoietik Kök Hücre Nakli Tek Merkez Deneyimi
PEKCAN G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)
2019
2019POSTTRANSPLANT LENFOSİTOZ ÖNEMLİ BİR PARAMETRE MİDİR?
CENGİZ SEVAL G., USLU A., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Tam Metin Bildiri)
2019
2019T-All Hastalarında Allojeneik Hematopoetik Kök Hücre Nakli Sonrasında Nelarabin Tedavisi Graftı Kurtarabilir mi?
CENGİZ SEVAL G., USLU A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)
2019
2019Refrakter Akut Lösemili Hastalarda Ardışık Kurtarma Tedavisi İle Birlikte Ahkhn Yeterli Kür Sağlayabilir mi?
CENGİZ SEVAL G., KIRCALİ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)
2019
2019Plerixafor, Periferik Kök Hücre Ürününde Akım Sitometri İle Saptanabilen Klonal Plazma Hücre Kontaminasyonunu Etkiler Mi?
CENGİZ SEVAL G., USLU A., DALVA K., BAKANAY ÖZTÜRK Ş. M., MERTER M., ŞAHİN U., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 02 Mart 2019, ss.74-75, (Özet Bildiri)
2019
2019Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.
ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019, (Tam Metin Bildiri)
2019
2019Akut Miyeloid Lösemide Nakil Öncesi Minimal Kalıntı Hastalık Diğer Risk Faktörlerinden Daha Önemli Midir?
NARLI ÖZDEMİR Z., ŞAHİN U., BALTACI M. A., USLU A., ÖZTÜRK C., CENGİZ SEVAL G., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 02 Mart 2019, ss.76-77, (Özet Bildiri)
2019
2019Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.
ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019, cilt.25, ss.322, (Tam Metin Bildiri)
2019
2019Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.
ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019, (Tam Metin Bildiri)
2019
2019MİYELOM HASTALARINDA OHKHN ÖNCESİ KULLANILAN İLAÇLARIN CMV REAKTİVASYONU ÜZERİNE SAĞKALIMI AZALTICI ETKİSİ OLABİLİR Mİ?
YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., ÖZTÜRK C., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Tam Metin Bildiri)
2019
2019CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?
CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019, (Tam Metin Bildiri)
2019
2019Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.
ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019, (Tam Metin Bildiri)
2019
2019Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.
ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019, (Tam Metin Bildiri)
2019
2019Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)
SEVAL G. C., ATİLLA E., ULAŞ B. B., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 20 - 24 Şubat 2019, cilt.25, ss.176-177, (Tam Metin Bildiri)
2018
2018İmmun Trombositopeni (İTP) hastalarında ABO kan gruplarının birinci basamak tedavi yanıtına etkisi
AKKUŞ E., FİDAN Ç., KUŞTAŞ A. A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
TKBD Uluslararası Katılımlı Hematolojik Hastalıkların Tanı Ve İzleminde Laboratuvar Sempozyumu, Türkiye, 5 - 07 Nisan 2018, cilt.16, ss.44, (Özet Bildiri)
2018
2018Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF
DEMİRER T., AYLI M., ÖZCAN M., GÜNEL N., HAZNEDAR R., DAĞLI M., et al.
BRITISH JOURNAL OF HAEMATOLOGY, 1 Ocak - 30 Aralık 2018, cilt.116, ss.468-474, (Özet Bildiri)
2018
2018Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience
SEVAL G. C., ULAŞ B. B., Taşçı O., Özel F., Bulat B., KUZU I., et al.
60th ASH Annual Meeting, San Diego, Amerika Birleşik Devletleri, 30 Kasım - 05 Aralık 2018, (Tam Metin Bildiri)
2018
2018Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience
TOPÇUOĞLU P., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.
60th ASH Annual Meeting, san diego, Amerika Birleşik Devletleri, 29 Kasım - 05 Aralık 2018, cilt.132, ss.5776, (Tam Metin Bildiri)
2018
2018Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience
GÜRMAN G., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
60th ASH Annual Meeting Exposition, san Diego, 29 Kasım - 04 Aralık 2018, cilt.132, ss.4673, (Tam Metin Bildiri)
2018
2018Residual Clonal Plasma Cells Detected by Flow Cytometry at 10-4 Level within Autologous Stem Cell Grafts is Associated with Significantly Less Overall Survival
CENGİZ SEVAL G., DALVA K., BAKANAY S., MERTER M., ŞAHİN U., USLU A., et al.
60th American Society of Hematology Annual Meeting, San Diego, CA, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, ss.3438, (Özet Bildiri)
2018
2018Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients
ATİLLA E., TOPÇUOĞLU P., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., DEMİRER T., et al.
60th ASH Annual Meeting, 30 Kasım - 05 Aralık 2018, (Özet Bildiri)
2018
2018The Outcome of Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Isolated CD4(+) T-cell Deficiency with Interleukin-2 Inducible T-cell Kinase (ITK) Gene Defect
YÜKSEL M., NARLI ÖZDEMİR Z., ŞAHİN U., ÇAĞDAŞ AYVAZ D. N., TURKUM ATIKCAN D., SERTESEN E., et al.
44th Annual Meeting of European Society for Blood and Marrow Transplantation, Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.533-534, (Özet Bildiri)
2018
2018İndüksiyon Mu Hazırlama Rejimi Mi Daha Önemli? İndüksiyon Sonrası Kalıntı Hastalığın Saptanamaması Bir Prognostik Gösterge Olabilir
CENGİZ SEVAL G., BAKANAY ÖZTÜRK Ş. M., MERTER M., ŞAHİN U., USLU A., NARLI ÖZDEMİR Z., et al.
44. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.161-162, (Tam Metin Bildiri)
2018
2018Hematopoietik kök hücre nakli için toplanan kemik iliği materyallerinde sayılan cd34 pozitif hücreler: Cd34 pozitif gen hematogonlara dikkat
DALVA K., Öz m. d., hakkoloğlu ş., avcu f., ERTEM M., İLHAN O., et al.
44. ulusal hematoloji kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
2018ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİL SONUÇLARINA ETKİLERİ
KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
2018Hematopoietik kök hücre nakli için toplanan kemik iliği materyallerinde sayılan Cd34 pozitif hücreler: CD34pozitif genç hematogonlara dikkat
DALVA K., Öz m. d., hakkoloğlu ş., ipek ş., öztürk a., taşkır f., et al.
44. ulusal hematoloji kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)
2018
2018ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİLSONUÇLARINA ETKİLERİ
KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)
2018
2018Promising utilization areas of theurapeutic plasmapheresis in cardiovascular surgery practice
DURDU M. S., ÇAKICI M., GÜMÜŞ F., ÇUBUKÇUOĞLU DENİZ G., CİVRİZ BOZDAĞ S., DİKMEN YAMAN N., et al.
Türk Kalp ve Damar Cerrahisi Derneği 15. Kongresi, Türkiye, 26 - 29 Ekim 2018, cilt.26, (Tam Metin Bildiri)
2018
2018Yüksek PRA Düzeyi Olan Böbrek Nakli Alıcılarında Plazmaferez , IVIG ve Ritüksimab Tedavisinin Etkinliği
ORS SENDOGAN D., SARITAŞ H., KUMRU G., İLHAN O., TÜZÜNER A., KEVEN K., et al.
Ulusan Nefroloji, Hipertansiyon, Diyaliz ve tRansplantasyon Kongresi, Antalya, Türkiye, 3 - 07 Ekim 2018, (Özet Bildiri)
2018
2018AKUT LÖSEMİ HASTALARINDA HLA UYUŞUMSUZLUĞUNUN NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ
CENGİZ SEVAL G., NARLI ÖZDEMİR Z., TATAR L., SÖKMEN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
2018Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience
Cengiz Seval G., BULAT B., Ozel F., Tasci O., Kuzu I., CİVRİZ BOZDAĞ S., et al.
ASCO Annual Meeting 2018, 1 - 05 Haziran 2018, cilt.36, ss.19525, (Tam Metin Bildiri)
2018
2018Akut karaciğer yetmezliğinde plazmaferezin etkinliği
SANDAL S., ZEYBEK İ., TUNA KIRSAÇLIOĞLU C., ALTUNTAŞ C., DEMİR E., KENDİRLİ T., et al.
12.Ulusal Çocuk Gastroenteroloji, Hepatoloji ve BESLENME kONGRESİ, Türkiye, 18 - 21 Nisan 2018, (Özet Bildiri)
2018
2018Heparin enhances CD34 content of stem cells collected following G-CSF +/- chemotherapy
MERTER M., ŞAHİN U., YILDIRIM Y., İLHAN O., BEKSAÇ M.
44th Annual Meeting of European Society for Blood and Marrow Transplantation, Lizbon, Portekiz, 18 - 21 Mart 2018, (Özet Bildiri)
2018
2018Fit Elderly Patients with aggressive lymphoma do not need dose reduction of conditioning regimen
İLHAN O., CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
44th Annual Meeting of the European Society for Blood and Marrow Transplantation, 18 - 21 Mart 2018, (Tam Metin Bildiri)
2018
2018Impact of Hepatitis B Core Antibody Seopositivity on the Liver Function Tests after Autologous Hematopoietic Stem Cell Transplantation For Multiple Myeloma
CENGİZ SEVAL G., SERTESEN E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
44th Annual Meeting of the European Society for Blood and Marrow Transplantation, 18 - 21 Mart 2018, (Tam Metin Bildiri)
2018
2018BlastIc Plasmacyto Id DendrItIc Cell Neoplasm: SIngle CenterExperIence on a Rare Hematological Malignancy
NARLI ÖZDEMİR Z., SEVAL G. C., USLU A., GÜNDÜZ M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
5th Aegean Hematology Oncology Symphosium, Yunanistan, 23 Eylül 2018, (Özet Bildiri)
2018
2018Donor lymphocyte infusion after salvage chemotherapy inrelapsed acute myeloblastic leukemia patients afterallogeneic stem cell transplantation
USLU A., SEVAL G. C., CİVRİZ BOZDAĞ S., GÜRMAN G., DEMİRER T., ARSLAN Ö., et al.
The 44th Annual Meeting of the European Society for Blood andMarrow Transplantation: Physicians Poster Sessions, lizbon, Portekiz, 18 - 21 Mart 2018, (Tam Metin Bildiri)
2018
2018ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI GELİŞENKARACİĞER SİNÜZOİDAL TIKANIKLIK SENDROM İNSİDANSIVE KLİNİK BULGULAR
GÜNDÜZ M., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
10. ULUSAL KEMİK İLİĞİTRANSPLANTASYONU VEHÜCRESEL TEDAVİLER KONGRESİ, Antalya, Türkiye, 1 - 03 Mart 2018, (Özet Bildiri)
2018
2018Allojeneik Hematopoetik Kök Hücre Nakli Sonrası Akut Myeloid Lösemi Nüksünün Yönetimi ve Prognozu
ŞAHİN U., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., ÖZEN M., CİVRİZ BOZDAĞ S., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2018, ss.126-127, (Özet Bildiri)
2018
2018Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
ARSLAN Ö., ELÇİN A. E., ATİLLA E., Şeker Ş., Baydın P., Gündüz M., et al.
ASBMT 2018, 21 - 25 Şubat 2018, cilt.24, ss.152-153, (Özet Bildiri)
2018
2018Ph Negatif ALL’de 1. Tam Remisyonda Yapılan Pekiştirme Tedavileri Nakil Sonrası Başarıyı Arttırır
NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2018, ss.107-108, (Özet Bildiri)
2018
2018Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma
İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2018 BMT Tandem Meetings, 21 - 25 Şubat 2018, cilt.24, ss.140, (Tam Metin Bildiri)
2018
2018Retrospective Analysis Learn Conditioning for Autologous Stem Cell Transplantation
SOYDAN E., GÖKMEN A., İLHAN O., ARSLAN Ö., ÖZCAN M.
Blood @marrow translant Res, 21 - 25 Şubat 2018, (Özet Bildiri)
2017
2017Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma
ATİLLA E., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.
American Society of Hematology, 8 - 12 Aralık 2017, (Özet Bildiri)
2017
2017Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma
İLHAN O., Güldane C., TOPRAK S. K., TOPÇUOĞLU P., Özel F., CİVRİZ BOZDAĞ S., et al.
American Society of Hematology, 8 - 12 Aralık 2017, (Özet Bildiri)
2017
2017Hematolojik Maligniteli Hastalarda Haploidentik Kök Hücre Nakillerinde Mezenkimal Kök Hücre Uygulaması
ARSLAN Ö., ELÇİN A. E., ATİLLA E., ŞEKER Ş., BAYDIN P., GÜNDÜZ M., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)
2017
2017Hematolojik Maligniteli Hastalarda Haploidentik Kök Hücre Nakillerinde Mezenkimal Kök Hücre Uygulaması.
ARSLAN Ö., ELÇİN A. E., ATİLLA E., ŞEKER Ş., BAYDIN P., GÜNDÜZ M., et al.
43.ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 1 - 04 Kasım 2017, (Özet Bildiri)
2017
2017Engrafmanın Erken Belirteci: Büyük Boyanmamış Hücreler
Aydın T., MERTER M., ŞAHİN U., Pekcan G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.53, (Özet Bildiri)
2017
2017İmmun Trombositopenide (İTP) Yenilikler Işığında Klinik Retrospektif Değerlendirme: Tek Merkez Deneyimi
AKKUŞ E., KUŞTAŞ A. A., PEKCAN G., MERTER M., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.98-99, (Özet Bildiri)
2017
2017OTOLOG PERİFERİK KÖK HÜCRE NAKLİNDE KÖK HÜCRESAKLANMA SÜRESİ ENGRAFMAN SÜRESİNİ ETKİLER Mİ?
MERTER M., Güleç B., Özcan G., Zehra Özdemir Z., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.220, (Özet Bildiri)
2017
2017TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARINSIKLIĞININ SAPTANMASINA YÖNELİK ÇALIŞMA
İLHAN O., ÖZET G., FALAY M., YENEREL M. N., TURGUT M., ÜNAL A., et al.
43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 05 Kasım 2017, (Tam Metin Bildiri)
2017
2017Türkiye’den Çok Merkezli Erken Erişim Program Sonuçları: Daha Önce Yoğun Tedavi Almış Relaps/Refrakter Multipl Miyelom Hastalarında Daratumumabın Etkililik ve Güvenliliği
BEKSAÇ M., GOKER H., TURGUT M., AYDIN Y., BESİSİK S., Cagirgan S., et al.
Türk Hematoloji Derneği, Türkiye, 17 - 20 Ağustos 2017, (Özet Bildiri)
2017
2017Evaluating peritransplant albumin decline as a predictor of acute graft versus host disease
MERTER M., YÜKSEL M., demir e., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, Fransa, 26 - 29 Mart 2017, cilt.52, ss.210-211, (Özet Bildiri)
2017
2017The outcome of haploidentical hematopoietic celltransplantations
ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, cilt.52, ss.314, (Özet Bildiri)
2017
2017Peripheral blood stem cell mobilization and collectionfrom elderly patients (≥65 years) with multiple myeloma: Asingle center experience
seval g. c., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, cilt.52, (Özet Bildiri)
2017
2017peripheral blood stem cell mobilization and collection from elderly patients with multiple myeloma:A single center experience
seval g., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
ebmt 2017, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Allogeneic hematopoietic stem cell transplantation(allo-HSCT) in advanced age adults: is it possible totransplant safely?
ATİLLA E., baŞ o., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, cilt.52, ss.272-273, (Özet Bildiri)
2017
2017ALLOEGENEİC HEMATOPOİETİC STEM CELL TRANSPLANTATİON İN ADVANCED AGE ADULTS:İS İT POSSİBLE TO TRANSPLANT SAFELY?
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., AKAN H., et al.
ebmt2017, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017The outcome of haploidentical stem cell transplantation
ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
ebmt 2017, 22 - 25 Haziran 2017, (Özet Bildiri)
2017
2017AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE
TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
22nd Congress of the European-Hematology-Association, 22 - 25 Haziran 2017, (Özet Bildiri)
2017
2017Autologous Stem Cell Trnasplantation for Mantle Cell Lymphoma: A Single Center Exprience
TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Exprience22nd Congress of the European Hematolgy Association, 22 Haziran - 25 Mayıs 2017, (Özet Bildiri)
2017
2017A single center experience with two decades of follow-up on patients with hairy cell leukemia.
İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2 - 06 Haziran 2017, (Özet Bildiri)
2017
2017Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma
İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
53rd Annual Meeting, 2 - 06 Haziran 2017, (Özet Bildiri)
2017
2017Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantationd for acute myeloid leukemia
GÜRMAN G., AYDEMİR GULOKSUZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
leukemia53rd Annual Meeting, 2 - 06 Haziran 2017, (Özet Bildiri)
2017
2017Allojeneik stem cell transplantation results in our myelodysplastic sydrome (MDS) patientes
GÜRMAN G., ATACA ATİLLA P., AYDIN T., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
patientes53rd Annual Meeting Jun 2-6, 2017, 2 - 06 Haziran 2017, (Özet Bildiri)
2017
2017A single center experience With two decades of follow-up on patients With hairy cell leukemia
İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
3rd Annual Meeting Jun 2-6, 2017, 2 - 06 Haziran 2017, (Özet Bildiri)
2017
2017Large Unstained Cell Percentage as a Predictor of Efficacious Peripheral Stem Cell Mobilization
MERTER M., KÖKEN K., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 Mayıs 2017, (Özet Bildiri)
2017
2017A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be
PEKCAN G., KURT YÜKSEL M., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Türkiye, 11 - 13 Mayıs 2017, ss.112, (Özet Bildiri)
2017
2017Evalauting peritransplant albümin decline as a predictor os acute graft versus host disease
MERTER M., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.
43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Allegeneic Hematopoetic Stem Cell Trnasplantation (Allo-HSCT) in advanced age adults:Is it possible to transplant safely?
ATİLLA E., BAŞ Ö., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Large Unsatained Cell (LUC) percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation
MERTER M., KÖKEN K., YÜKSEL M., DEMİR N., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Herpes SimplexVirus infection in patients after allogeneic hematopoetic stem cell transplantation
ATİLLA E., ÖZEL F., YILMAZ V., ATACA ATİLLA P., ATEŞAĞAOĞLU B., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Peripheral Blood Stem Cell Mobilization and collection from elderly patients 65 years with multipl myeloma: A , single center exprience
CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017The outcome of Haploidentical Hematopoietic Celll Trnasplantations (Haplo HSCT)
ATİLLA E., ECE B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Acute GVHD and unreated/haploidentical Trnasplants incrreses the incidence of hemorrhagic cystitis in Allo- HSCT Recipients
TOPÇUOĞLU P., ATİLLA E., ATACA ATİLLA P., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)
2017
2017Management and Outcome of Central Nerve System(CNS) Involvement in Acute Lymphoblastic Leukemia
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
BMT Tandem Meetings, orlando, Amerika Birleşik Devletleri, 22 - 26 Şubat 2017, cilt.23, ss.251, (Özet Bildiri)
2017
2017Management and Outcome of Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL)
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
BMT Tandem Meetings, 22 - 26 Şubat 2017, (Özet Bildiri)
2017
2017Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients
GÜRMAN G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
BMT Tandem Meetings, 22 - 26 Şubat 2017, (Özet Bildiri)
2017
2017Allogeneic stem cell transplantation for chonic lymphocytic Leukemai
ATİLLA E., ATACA ATİLLA P., pekcan g., İLHAN O., GÜRMAN G., ÖZCAN M., et al.
BMT TANDEM MEETINGS, 22 - 26 Şubat 2017, (Özet Bildiri)
2016
2016Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia CLL
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.
ASH, 3 - 06 Aralık 2016, (Özet Bildiri)
2016
2016Comparison of Reduced Intensity Conditioning RIC Regimen and Myeloablative Conditioning MAC Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT for Adult Patients with Acute Leukemia
GÜRMAN G., AYDEMİR GÜLÖKSÜZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
ASH, 3 - 06 Aralık 2016, (Özet Bildiri)
2016
2016AKUT MYELOİD LÖSEMİDE FLOW SİTOMETRİ İLEİNDÜKSİYON SONRASI TESPİT EDİLEN CD34 HÜCRESAYISI SAĞKALIM VE RELAPSI ETKİLER
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., TOPRAK S. K., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016ALLOJENEİK KÖK HÜCRE NAKLİ OLAN AKUTLÖSEMİLERDE HAZIRLIK REJİMLERİNİNKARŞILAŞTIRILMASI
GÜLÖKSÜZ G. A., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016KRONİK LENFOSİTİK LÖSEMİ DE TANI ANINDAHİPOGAMAGLOBULİNEMİ SAĞKALIM VE ENFEKSİYONRİSKİ ÜZERİNDE ETKİLİ MİDİR
ATACA ATİLLA P., ATİLLA E., PEKCAN G., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016ALLOJENEİK KÖK HÜCRE NAKLİ YAPILANHASTALARDA PERİTRANSPLANT ALBUMİN DÜŞÜŞÜİLE GVHD İLİŞKİSİ
MERTER M., Şah F. T., ŞAHİN U., YALÇINER M., Kocabay H. E., CİVRİZ BOZDAĞ S., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016TROMBOTİK MİKROANJİOPATİDE TERAPÖTİKPLAZMA DEĞİŞİMİ
ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., TOPÇUOĞLU P., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.
42. Ulusal Hematoloji, Türkiye, 19 - 22 Ekim 2016
2016
2016MYELODİSPLASTİK SENDROM HASTALARININOGATA SKORLAMASI İLE FLOW SİTOMETRİKOLARAK DEĞERLENDİRİLMESİ
ATİLLA E., ATACA ATİLLA P., TÜREDİ Ö., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
42.Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016GRAFT VERSUS HOST HASTALIĞINDAEKSTRAKORPOREAL FOTOFEREZİN YERİ
GÜNDÜZ M., ATİLLA E., ATACA ATİLLA P., AKAY B. N., ŞANLI H., TOPÇUOĞLU P., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016ALLOJENEİK KÖK HÜCRE NAKİL ÖNCESİ FAZLAKİLOLU OBEZ OLMANIN SAĞKALIM VE NÜKS İLEİLİŞKİSİ
ATİLLA E., ATACA ATİLLA P., CEYLAN A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42.ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 19 - 22 Ekim 2016
2016
2016ALLOJENEİK KÖK HÜCRE NAKLİ HASTALARIMIZDAGELİŞEN KATATER TROMBOZLARI
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., TOPRAK S. K., YÜKSEL M., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016PRİMER MYELOFİBROZİS TE ALLOJENEİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ
CENGİZ G. S., GÜNDÜZ M., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016AKUT LENFOSİTİK LÖSEMİDE ALL SANTRAL SİNİRSİSTEMİ SSS TUTULUMUNA YAKLAŞIM
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
42.Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016PERİFERİK T HÜCRELİ LENFOMALARDA OTOLOGHEMATOPOETİK KÖK HÜCRE TRANSPLANTASYONU TEK MERKEZ DENEYİMİ
ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016
2016
2016Anti HLA Antikor Varlığının Allojeneik Kök Hücre Nakli Yapılan Hastalarda Engrafman Üzerine Etkisi: Tek Merkez Deneyimi
MERTER M., AYDOĞAN M., TEKEŞ M. A., ŞAHİN U., AYYILDIZ Ö. M., KOCABAY H. E., et al.
42. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 19 - 22 Ekim 2016, ss.60-61, (Özet Bildiri)
2016
2016BEING OVERWEIGHT PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IS RELATED TO BETTER SURVIVAL
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.
78.th Annual Meeting of the Japanese Society of Hematology, 13 - 15 Ekim 2016
2016
2016IS IT POSSIBLE TO DIAGNOSE LOW RISK MYELODYSPLASTIC SYNDROME MDS BY FLOW CYTOMETRY
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., BEKSAÇ M., et al.
EHA, 9 - 12 Haziran 2016
2016
2016OUR APPROACH TO HAIRY CELL LEUKEMIA HCL 31 YEARS OF EXPERIENCE
ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
EHA, 9 - 12 Haziran 2016
2016
2016CD34 POSITIVE CELL COUNT DETECTED BY MULTI COLOR FLOW CYTOMETRY MFC AFTER FIRST INDUCTION THERAPY IN ACUTE MYELOID LEUKEMIA AML EFFECTS ON SURVIVAL AND RELAPSE
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
EHA, 9 - 12 Haziran 2016
2016
2016MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM CNS INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA ALL PRE AND POST TRANSPLANT Conference 21st Congress of the European Hematology AssociationLocation Copenhagen DENMARK
ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
21st Congress of the European-Hematology-AssociationLocation: Copenhagen, DENMARK, 9 - 12 Haziran 2016, cilt.101
2016
2016BEING OVERWEIGHT OBESE PRIOR TO ALLOJENEIK HEMATOPOIETIC STEM CELL TRANSPLANTATION ALLO HSCT IS RELATED TO BETTER OVERALL SURVIVAL OS AND DECREASED NON RELASE MORTALITY
ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.
EHA, 9 - 12 Haziran 2016, (Özet Bildiri)
2016
2016EXTRACORPOREAL PHOTOPHERESIS SAFE AND EFFECTIVE FOR THE TREATMENT OF MYCOSIS FUNGOIDES
ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAY B. N., ŞANLI H., et al.
EHA, 9 - 12 Haziran 2016, (Özet Bildiri)
2016
2016THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA PATIENTS SINGLE CENTER EXPERIENCE
MERTER M., ŞAHİN U., GÜNDÜZ M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., İLHAN O.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016
2016
2016THERAPEUTIC THROMBOCYTAPHERESIS HIGHER PLATELET COUNTS SHOULD MATTER
NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016
2016
2016ARE AGE AND JAK2V617F MUTATION RELATED TO THROMBOSIS IN CHRONIC MYELOPROLIFERATIVE DISEASES
ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., AKAN H., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016
2016
2016THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY
ATİLLA E., ATACA ATİLLA P., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016
2016
2016Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma
İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
ASCO, 3 - 07 Haziran 2016, (Özet Bildiri)
2016
2016Effect of Cytomegalovirus Reactivation on Prognosis After Allogeneic Transplantation for Acute Leukemia with Active Disease Conditioned with a Sequential Regimen and Anti Thymocyte Globulin
GÜNDÜZ M., YÜKSEL M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 3 - 06 Nisan 2016
2016
2016THE EFFICACY OF TYROSINE KINASE INHIBITORS WITH STEROID IN Ph ACUTE LYMPHOBLASTIC LEUKEMIA
GÜRMAN G., MERTER M., ATİLLA E., ŞAHİN U., TOPÇUOĞLU P., ARSLAN Ö., et al.
ASCO, 3 - 07 Haziran 2016, (Özet Bildiri)
2016
2016Succesfull treatment in primary central nervous system lymphoma
ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., İLHAN O., et al.
ASCO, 3 - 07 Haziran 2016, (Özet Bildiri)
2016
2016AKTİF HASTALIKLI AKUT LÖSEMİDE ATG VEHAZIRLIK REJİMİ İLE ALLOJENİK NAKİL SONRASICMV REAKTİVASYONUNUN PROGNOZA ETKİSİ
GÜNDÜZ M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 3 - 05 Mart 2016
2016
2016PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİHASTALARINDA ALLOJENEİK HEMATOPOETİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ
NARLI ÖZDEMİR Z., TOPRAK S. K., TOPÇUOĞLU P., ŞAHİN U., GÜNDÜZ M., ATİLLA E., et al.
9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 3 - 05 Mart 2016
2016
2016Efficacy of High Dose Corticosteroid Premedication for the Prevention of Anti thymocyte Globulin Related Side Effects
MERTER M., ŞAHİN U., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation Location, 1 - 02 Mart 2016
2016
2016Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation
ŞAHİN U., YÜKSEL M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Kıbrıs (Kktc), 1 - 02 Mart 2016, (Özet Bildiri)
2015
2015Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia Subgroup Analysis of the Green Study
İLHAN O.
blood journal, 3 - 05 Aralık 2015
2015
2015NILOTINIB RESULTS IN IMPROVED RATES OF MOLECULAR RESPONSE IN TURKISH NEWLY DIAGNOSED CML CP PATIENTS A 24 MONTH UPDATE
SAYDAM G., HAZNEDAROĞLU İ. C., İLHAN O., KAYNAR L., ALİ R., GÜVENÇ B., et al.
HAEMATOLOGICA, 11 - 14 Haziran 2015
2015
2015MULTICENTER RETROSPECTIVE ANALYSIS OF TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
İLHAN O., SAYDAM G., HAZNEDAROĞLU İ. C., ÜNAL A., UĞUR BİLGİN A.
HAEMATOLOGICA, 11 - 14 Haziran 2015
2015
2015Does chronic lymphocytic leukemia occur in younger adults in Turkey
ARSLAN Ö., TOPÇUOĞLU P., ATİLLA E., ÖZCAN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015
2015
2015Allogeneic stem cell transplantation results in our myelodysplastic syndrome MDS patients
ATACA P., İLHAN O., ARSLAN Ö., TOPÇUOĞLU P., ATİLLA E., AKAN H.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015, (Özet Bildiri)
2015
2015Azacitidine in combination with ATRA valproic acid in elderly AML patients
ÖZCAN M., CİVRİZ BOZDAĞ S., İLHAN O., YÜKSEL M., ATACA P., ATİLLA E., et al.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015
2015
2015CML leukemic stem cell CML LSC Its existence in patients who achieved cytogenetic molecular response under treatment of TKI
İLHAN O., TOPRAK S. K., USLU A., ATİLLA E., ARSLAN Ö., ÖZCAN M., et al.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015
2015
2015Autologous Stem Cell Transplantation in Elderly Patients 60 years with Myeloma or Lymphoma Single Center Experience
gündüz m., ATACA P., ATİLLA E., gültekin p., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Single Centre Experienc
ŞAHİN U., MERTER M., ATİLLA E., TOPÇUOĞLU P., TOPRAK S. K., İLHAN O., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015Different Doses of Anti Thymocyte Globulin ATG in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation
gültekin p., ateşağaoğlu b., MERTER M., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015Is it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation HSCT using Plasma Exchange PE A Single Center s Experience
YÜKSEL M., gültekin p., bay m., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015, (Özet Bildiri)
2015
2015upper and lower respiratory tract infections by respiratory viruses in adult recipients of allogeneic hematopoeitic stem cell transplantation Allo HSCT Single center
ŞAHİN D., ATİLLA E., USLU A., ATACA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015Allogeneic Stem Cell Transplantation for Hodgkin and non Hodgkin Lymphoma Single center experience
ATİLLA E., MERTER M., ATACA P., TOPRAK S. K., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015Erythrocytosis following allogeneic hematopoietic stem cell transplantation in six cases
gültekin p., ATACA P., ATİLLA E., TOPRAK S. K., İLHAN O., TOPÇUOĞLU P., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015Effect of pretransplant body mass index on the clinical outcome after allogeneic stem cell transplantation in patients with hematologic malignancies a single center experience
GÖKMEN A., ender s., YÜKSEL M., İLHAN O., ARSLAN Ö., ÖZCAN M.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015
2015
2015HLA A allele mismatch 7 8 or 9 10 is the second best option after 8 8 or 10 10 matched unrelated donors An analysis on results from Turkish centers
BEKSAÇ M., TOPÇUOĞLU P., ARAT M., İLHAN O., GÜRMAN G., zafer g.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015, (Özet Bildiri)
2015
2015Characterization and MicroRNA Expression Profile Analysis of Mesenchymal Stem Cells Derived From Myelodysplastic Syndrome and Acute myeloid leukemia AML Patients and Comparison with Healthy Controls
özdoğan h., ATALAY A., İLHAN O.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015, (Özet Bildiri)
2015
2015Upper and Lower Respiratory Tract Infections by Respiratory Viruses by Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Single Center Experience
ŞAHİN D., ATİLLA E., CİVRİZ BOZDAĞ S., ATACA P., TOPRAK S. K., TOPÇUOĞLU P., et al.
41th EBMT Meeting, 22 - 25 Mart 2015, (Özet Bildiri)
2015
2015Generic Bioequivalent Melphalan Has Similar Efficacy and Toxicity but Lower Cost in the Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S440
TOPÇUOĞLU P., GÜLTAY D., ÖZTÜRK N., KILIÇ Ö., OKAY M., ERASLAN KARADAĞ Y., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015, (Özet Bildiri)
2015
2015Impact of Pre transplant Serum Ferritin on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
UĞUR Ş., ERDAL H., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015, (Tam Metin Bildiri)
Kitaplar
2020
2020Editöryal
İLHAN O., TOPRAK S. K.
Hematoloji ve COVID-19 - 2020 (Kitap Editörlüğü), İlhan Osman, Toprak Selami Koçak, Editör, Türkiye Klinikleri, Ankara, ss.1-116, 2020
Kongre ve Sempozyum Katılımı Faaliyetleri
27 Nisan 2025 - 27 Nisan 2025
27 Nisan 2025 - 27 Nisan 202513. türkkök 1. aybükök kök hücre kongresi
Davetli Konuşmacı
Ankara-Türkiye
26 Nisan 2025 - 26 Nisan 2025
26 Nisan 2025 - 26 Nisan 20254. uluslararası katılımlı hematolojik malignitelerde kemoterapi dışı hedefe yönelik tedaviler sempozyumu
Davetli Konuşmacı
Muğla-Türkiye
25 Nisan 2025 - 25 Nisan 2025
25 Nisan 2025 - 25 Nisan 202513. izmir hematoloji sempozyumu
Oturum Başkanı
İzmir-Türkiye
17 Nisan 2025 - 19 Nisan 2025
17 Nisan 2025 - 19 Nisan 202517. ulusal kemik iliği transplantasyonu ve hücresel tedaviler kongresi
Davetli Konuşmacı
Antalya-Türkiye
10 Nisan 2025 - 12 Nisan 2025
10 Nisan 2025 - 12 Nisan 202510. Ulusal Kan ve Kemik İliği Nakil Kongresi
Oturum Başkanı
Lefkoşa-Kıbrıs (Kktc)
04 Nisan 2025 - 06 Nisan 2025
04 Nisan 2025 - 06 Nisan 20259. AKDENİZ HEMATOLOJİ SEMPOZYUMU
Oturum Başkanı
Antalya-Türkiye
11 Ocak 2025 - 11 Ocak 2025
11 Ocak 2025 - 11 Ocak 202517. New Trends In Hematology
Oturum Başkanı
İstanbul-Türkiye
21 Aralık 2024 - 21 Aralık 2024
21 Aralık 2024 - 21 Aralık 20247. Multidisipliner Kök Hücre Öğrenci Kongresi
Davetli Konuşmacı
Ankara-Türkiye
21 Aralık 2024 - 21 Aralık 2024
21 Aralık 2024 - 21 Aralık 2024San Dıego Sonrası 2024 Biterken Lösemi Lenfoma Miyelom Güncellemesi
Oturum Başkanı
Ankara-Türkiye
07 Aralık 2024 - 10 Aralık 2024
07 Aralık 2024 - 10 Aralık 202466. American Hematoloji Association (ASH) Kongresi
Katılımcı
California-Amerika Birleşik Devletleri
30 Kasım 2024 - 30 Kasım 2024
30 Kasım 2024 - 30 Kasım 20241. OMÜKÖK Kök Hücre Kongresi
Oturum Başkanı
Samsun-Türkiye
22 Kasım 2024 - 23 Kasım 2024
22 Kasım 2024 - 23 Kasım 2024KMPH Güncelleme Sempozyumu
Oturum Başkanı
Ordu-Türkiye
15 Kasım 2024 - 16 Kasım 2024
15 Kasım 2024 - 16 Kasım 202419. Ulusal Aferez Kongresi
Oturum Başkanı
İstanbul-Türkiye
08 Kasım 2024 - 10 Kasım 2024
08 Kasım 2024 - 10 Kasım 2024Aydın Hematoloji Günleri
Oturum Başkanı
İzmir-Türkiye
29 Ekim 2024 - 02 Kasım 2024
29 Ekim 2024 - 02 Kasım 202450. Ulusal Hematoloji Kongresi
Oturum Başkanı
Antalya-Türkiye
03 Ekim 2024 - 05 Ekim 2024
03 Ekim 2024 - 05 Ekim 202411. Hematolojik Onkoloji Kongresi
Oturum Başkanı
Lefkoşa-Kıbrıs (Kktc)
20 Eylül 2024 - 22 Eylül 2024
20 Eylül 2024 - 22 Eylül 202413. Ulusal Geriatrik Hematoloji Kongresi
Oturum Başkanı
Ankara-Türkiye
16 Eylül 2024 - 16 Eylül 2024
16 Eylül 2024 - 16 Eylül 2024Akut Lösemi Çalıştayı
Oturum Başkanı
Sinop-Türkiye
05 Eylül 2024 - 07 Eylül 2024
05 Eylül 2024 - 07 Eylül 20248. Hematolojik İmmünoloji Kongresi
Oturum Başkanı
İzmir-Türkiye
30 Ağustos 2024 - 01 Eylül 2024
30 Ağustos 2024 - 01 Eylül 2024Uluslararası Katılmalı Deneysel Hematoloji Kongresi
Oturum Başkanı
Gaziantep-Türkiye
29 Ağustos 2024 - 30 Ağustos 2024
29 Ağustos 2024 - 30 Ağustos 20243. Myeloma Lenfoma-Lösemi Çalıştayı
Oturum Başkanı
Lefkoşa-Kıbrıs (Kktc)
28 Haziran 2024 - 30 Haziran 2024
28 Haziran 2024 - 30 Haziran 202410. Karadeniz Hematoloji Kongresi
Oturum Başkanı
Samsun-Türkiye
13 Haziran 2024 - 16 Haziran 2024
13 Haziran 2024 - 16 Haziran 2024EHA (Avrupa Hematoloji Derneği)
Katılımcı
Madrid-İspanya
30 Mayıs 2024 - 01 Haziran 2024
30 Mayıs 2024 - 01 Haziran 2024Ulusal Kan ve Kemik iğili Kongresi
Oturum Başkanı
İstanbul-Türkiye
10 Mayıs 2024 - 11 Mayıs 2024
10 Mayıs 2024 - 11 Mayıs 2024